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ABSTRACT OF DISSERTATION 
 
 
DEVELOPMENT OF NEW BIOLOGICAL NANOPORES AND THEIR 
APPLICATION FOR BIOSENSING AND DISEASE DETECTION 
 
 
Nanopore technology has recently emerged as a new real-time single molecule sensing 
method. The current dominant technologies, such as mass spectrometry and immunoassay, 
for protein analysis is still slow and complex, which can’t meet the urgent need and fields 
of use.  Development of a highly simple, portable and sensitive detection system for 
pathogen detection, disease diagnosis, and environmental monitoring is in great need. 
Membrane embedded Phi29 connector nanopore, the first protein nanopore coming from 
bacteriophage, was mainly focusing on DNA and RNA translocation in previous studies. 
Here, Phi29 connector nanopore was first time established for antibody detection by 
engineering Epithelial Cell Adhesion Molecule peptide as a probe. The results demonstrate 
that the specific antibody can be detected in presence of diluted serum or non-specific 
antibody. To enable detecting more different types of analytes with high sensitivity, 
developing new nanopore with various properties, such as size, charge, 
hydrophilic/hydrophobic and physical dimension, is needed.  In this work, besides Phi29 
nanopore, several new protein nanopores that derived from T3, T4, and SPP1 
bacteriophages were developed. A shared property of three step conformational change 
among these portal channel has been discovered. Elucidating the sequence and oligomeric 
states of proteins and peptides is critical for understanding their biological functions.  Here, 
SPP1 nanopore was used to characterize the translocation of TAT peptide with dimer and 
monomer forms. Translocation of the peptide was confirmed by optical single molecule 
imaging for the first time, and analyzed quantitatively. The dynamics of peptide oligomeric 
states were clearly differentiated based on their characteristic electronic signatures. Main 
challenge for probing protein structure, folding, detection and sequencing using nanopore 
is the ultra-fast translocation speed which normally beyond electronic detection limit. In 
this work, the peptides translocation was slowed in SPP1 nanopore by changing the charge 
shielding of the channel. A 500-fold reduction was observed for TAT peptide translocation. 
By using this method, arginine chain peptide as short as two arginine can be detected first 
time. Further improving the bandwidth may lead to single amino acid detection and has the 
potential for protein sequencing. Compared with protein nanopore, de novo designed 
nanopore can provide numerous advantages, such as tunable size and functionality, ease of 
construction, scale up and modification. In the final study, an RNA-based biomimetic 
nanopore was first time constructed. The insertion of RNA nanopore into lipid bilayer and 
cell membrane were characterized and translocation of short amino acids through RNA 
nanopore was detected. This new artificial nanopore has the potential to be used for 
sensing, disease diagnosis, and even protein sequencing. 
 
KEYWORDS: Biological nanopore, peptide translocation, bacteriophage, RNA 
Nanotechnology, protein sequencing  
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Chapter 1: Introduction and Literature Review 
BRIEF SUMMARY: 
 Chapter 1 begins this thesis with an overview of the principle of nanopore and 
current state of this field.  First, the structure and properties of the most commonly used 
biological nanopore are summarized. Then, recent progresses in biological nanopores for 
DNA sequencing and single molecule sensing has been reviewed from a protein 
engineering standpoint. Several milestone studies illustrating the logic behind the 
engineering approaches have also been discussed. 
 Chapter 2 is a proof of concept study to demonstrate the feasibility of phi29 
connector nanopore for disease diagnosis. In the study, an Epithelial Cell Adhesion 
Molecule (EpCAM) peptide was engineered into the C-terminal of nanopore as a probe to 
specifically detect EpCAM antibody (Ab) in nano-molar concentration at the single 
molecule level. The binding of Abs sequentially to each peptide probe induced step-wise 
blocks in current. The signal of EpCAM antibody can be discriminated from the 
background events in the presence of non-specific antibody or serum. The results 
demonstrate the feasibility of generating a highly sensitive platform for detecting 
antibodies at low concentration in the presence of contaminants. 
 Chapter 3 explores more biological nanopore from other bacteriophages and 
discovers a three step gating property that is common to DNA packaging motors of 
bacterial viruses. The DNA packaging motor of dsDNA bacterial viruses contains a head-
tail connector with a channel for genome to enter during assembly and to exit during host 
infection. In this study, a three step conformational change of the portal channel that is 
common among DNA translocation motors of bacterial viruses T3, T4, SPP1, and phi29. 
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The channels of these motors exercise three discrete steps of gating, as revealed by 
electrophysiological assays. It is proposed that the three step channel conformational 
changes occur during DNA entry process, resulting in a structural transition in preparation 
of DNA movement in the reverse direction during ejection. 
 Chapter 4 expands the applications of portal protein to study the translocation of 
peptides and the dynamics of peptide oligomeric states in real-time at single molecule level. 
In this study, to acquire protein channels with larger pore sizes, we engineered a portal 
channel from bacteriophage SPP1 that allowed the translocation of peptides with higher 
ordered structures. Utilizing single channel conduction assay and optical single molecule 
imaging, we observed translocation of peptides quantitatively and analyzed the dynamics 
of peptide oligomeric states in real-time at single molecule level. The oxidative and the 
reduced states of peptides were clearly differentiated based on their characteristic 
electronic signatures. A similar Gibbs free energy (ΔG0) was obtained when different 
concentrations of substrates were applied, suggesting that the use of SPP1 nanopore for 
real-time quantification of peptide oligomeric states is feasible. With the intrinsic nature of 
size and conjugation amenability, the SPP1 nanopore has the potential for development 
into a tool for the quantification of peptide and protein structures in real time. 
          Chapter 5 optimizes the condition for short peptide detection based on the work from 
the forth chapters. Using nanpore for probing protein structure, folding, detection and 
sequencing is in early stage because it is still lack of an effective and simple method to 
slow down the ultra-fast translocation speed of peptide. In this work, the peptides 
translocation was slowed down in SPP1 DNA packaging motor with low NaCl 
concentration buffer. The underlying mechanism is that reduced charge screening effect 
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resulted from low salt concentration enhanced electrostatic attractive force between the 
peptide and pore, which therefore slow down peptide translocation speed. A factor of 500 
fold reduction was observed for TAT translocation. Appling such condition in detecting 
arginine chain peptide allows us to measure as short peptide as two arginine amino acids. 
Further improve the bandwidth may lead to single amino acid detection and protein 
sequencing. 
Chapter 6 constructs a new biomimetic RNA-based nanopore and applies for 
peptide detection. Creating a new pore de novo with the ability to accurately tune the size 
and its functionality is still of great interest in fundamental and applied science. One of the 
key challenges in the de novo design of membrane channel is, to achieve a defined 
architecture in atomic scale with defined size, shape and properties. Over the last decade, 
RNA nanotechnology has advanced rapidly and attracted widespread attention due to the 
potential for applications in material and medical sciences. Compared to DNA, RNA has 
higher diversity in structure and function. Due to their diversity in structures and functions, 
RNA molecules were used as building blocks for engineering various de novo architectures 
with unique physical/biochemical properties via bottom-up self-assembly. To expand 
biological nanopores and explore new features of artificial nanopores, in this study we 
constructed and assembled RNA nanopores with two different designs. The insertion of 
RNA nanopore into lipid bilayer and cell membrane were further characterized. 
Translocation of short amino acids through RNA nanopore was detected and characterized. 
Translocation of short amino acids is first time observed in artificial nanopore. This new 
artificial nanopore has the potential to be used for sensing, disease diagnosis and even 
protein sequencing. 
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 Chapter 7 briefly summarizes the major findings and advancements discussed in 
this thesis dissertation. Furthermore, the future direction of this work and perspectives of 
nanopore for sensing and sequencing is also discussed. 
 
HYPOTHESIS: 
 Biological nanopore particularly portal protein channels can be used for biosensing, 
disease diagnosis and even protein sequencing.  
INTRODUCTION: 
The intriguing design and elegant architecture of biological machines have inspired 
the development of nanopores for versatile applications in nanotechnology. The proof-of-
concept was established in 1996 using α-hemolysin pores, which can spontaneously insert 
into a planar lipid bilayer to generate a membrane-embedded nanopore system(1). In the 
electrochemical chamber, the lipid membrane separated the chamber into cis- and trans 
compartments filled with conducting buffer. Under an applied potential, single-stranded 
DNA, which is negatively charged can be electrically driven through the α-hemolysin 
channels to the positive terminal and the resulting translocation process was characterized 
using several parameters and verified by qRT-PCR(1). Since the landmark paper, in the 
last two decade, nanopore-based technology has demonstrated significant potentials for 
sensing a wide range of analytes and DNA sequencing, and is well positioned to bring a 
revolution to medical diagnostics and DNA sequencing arena (2). Compared with other 
technologies, nanopore offers numerous advantages (3-6): (1) It is a label-free and 
amplification-free approach; (2) It offers real time recognition at single molecule level; (3) 
It requires very low sample volumes with minimal sample processing; (4) Electrical 
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detection method is fast and can be carried out in parallel with multiple samples; and (5) 
Can detect target analyte with high specificity and sensitivity in the presence of a large 
amount of contaminants. 
To date, several protein channels such as α-hemolysin (7), MspA (8), Aerolysin (9), 
FluA (10), Omp F or G (11,12), and viral connectors Phi29 (13), SPP1 (14), T3(14) and 
T4(14) have been successfully used for incredibly versatile applications including 
detection of small molecules, macromolecule, polymers, polypeptides, as well as DNA and 
RNA (15-17). Protein engineering techniques, such as site directed mutagenesis, insertion, 
and deletion of amino acids, and introduction of functional modules have been extensively 
employed to tune the nanopore properties for target applications(18,19). Herein, we will 
summarize the recent progresses in engineering biological nanopores for sensing and 
sequencing applications and provide perspectives for future studies. We note that due to 
page limitations, we omitted the discussion on DNA-based biological nanopores (20,21) 
and solid state nanopore (22) counterparts, which have been reviewed in detail elsewhere 
(23-25).   
1. General strategies used in protein nanopore engineering  
Although biological systems contain a wide variety of channel forming proteins 
(18,26), only a handful have been deemed to be suitable for nanopore studies. A major 
limitation is the availability of the crystal structure. Without knowing the structure, it is 
nearly impossible to engineer the channel precisely and rationally by genetic or chemical 
modifications. Another challenge is our limited knowledge of how the structure of the 
protein channel relates to its function. Generally, to be a good protein nanopore candidate, 
wild type or modified protein channel needs to meet at least three criteria. First, it should 
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be very robust and retain channel forming capability after mutagenesis. Second, it should 
have appropriate geometry for either biosensing or sequencing applications. The physical 
dimensions and the geometry of the nanopore including the entrance, the vestibule, and the 
narrowest constriction, as well as biophysical properties of the pore such as the charge 
distribution and hydrophilic/hydrophobic residues can significantly affect the functioning 
of the nanopore. Third, it should be electrically quiescent, which means that in presence of 
conducting buffer and applied electrical potential, the current signal should be stable and 
not display any voltage gating phenomena. So far, several different engineering approaches 
have been employed either singly or in combination to change the intrinsic properties of 
biological nanopores such as for increasing the stability, changing the oligomeric state, 
introducing recognition sites and enhancing sensitivity. The first approach is based on site-
directed mutagenesis that substitutes specific amino acids at certain locations in the 
primary sequence and this method is widely used due to its inherent simplicity and 
widespread adaptability. The availability of a wide range of unnatural amino acids with 
unique side chain and functional properties have vastly expanded nanopore reengineering 
options. Common mutation sites of a-hemolysin and MspA and their effects are 
summarized (Fig1.1).  The second approach is to attach specific ligands either through 
protein expression or chemical conjugation to the different sites of the pore. The third 
approach is to introduce adapter ligands either covalently or non-covalently into the pore. 
The fourth approach is a bit more aggressive and involves truncation or insertion of several 
amino acids up to a chain segment.  
 
7	  
	  
 
Figure 1.1 Common mutation sites of a-hemolysin and MspA. Left: Structure of a-
hemolysin and MspA labeled with common mutation sites. Right: Mutations sites and the 
effect after mutation. 
 
 
 
 
 
 
 
 
 
 
 
 
8	  
	  
2. Structural basis of commonly used protein nanopores 
2.1 α-hemolysin (PDB: 3ANZ) 
α-hemolysin is a self-assembled heptamer with a molecular weight of 232 kDa 
(Fig.1.1). It was discovered from Staphylococcus aureus and has a hollow mushroom-like 
shape. The external dimensions of the pore is 10×10 nm (27). It is composed of “stem”, 
“rim” and “cap” domains. The 14-stranded trans-membrane β-barrel is in the stem part, 
assembled from seven hairpins. As revealed in the crystal structure (7), the inner diameter 
of the central channel is 2.6 nm at the cis entrance and 2.2 nm at the trans side. The 
vestibule is 3.6 nm at its widest part and the narrowest constriction is 1.4 nm in diameter. 
Several sites within the β-barrel has exhibited higher nucleotide-specific sensitivity with 
immobilized ssDNA (28). α-hemolysin can withstand temperatures close to 100°C and a 
wide range of pH from 2 to 12 while maintaining structural integrity (29). The conductance 
of α-hemolysin under 1M KCl is 1 nS per pore (30). Membrane insertion occurred 
spontaneously when monomeric α-hemolysin protein was added to the chamber.  
2.2 Mycobacterium smegmatis porin (MspA) (PDB: 1UUN)  
MspA is an octameric porin with a molecular weight of 160 kDa (31)(Fig 1.2). It 
was discovered from Mycobacterium smegmatis, and has a funnel shaped structure (8). The 
external dimension of the pore are 8.8×9.6 nm. As revealed in the crystal structure (32), 
the inner diameter of the central channel is 4.8 nm at the cis entrance and it has a ~1.2 nm 
long and ~0.6 nm wide constriction site that is flanked by regions with significantly large 
space (32). It has been proved that such physical geometry provides improved spatial 
resolution for DNA sequencing. As each nucleotide is threaded through the narrow part of 
the pore, it produces a unique fingerprint of ionic current blockades (33). This pore is very 
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robust and maintains channel forming activity at different harsh conditions, including 
incubation at 80°C in presence of 2% SDS, pH 0‒14; and even 100°C for 30 min after 
extraction (8,34). The wild-type MspA suffered from spontaneous gating without ssDNA 
under an applied voltage of >60 mV. The conductance of wildtype MspA under 1M KCl 
is 4.9 nS per pore (8) and the peak conductance of M1 MsPA mutant (D90N/D91N/D93N) 
is only 1.6 nS (35). Membrane insertion occurred spontaneously when monomeric MspA 
protein was added to the chamber. 
2.3 Aerolysin 
Aerolysin is a heptamer pore with a molecular weight of 332 kDa (Fig.1.2). It was 
discovered from the bacterium Aeromonas hydrophila (36,37). It is an exotoxin secreted 
as a single polypeptide chain (38). While a crystal structure is not yet available, a high 
resolution electron microscopy study revealed that aerolysin is 1‒1.7 nm diameter at the 
narrowest constriction (9,39). Overall, aerolysin is negatively charged (Z= ‒52e), while α-
hemolysin has slightly positive net charge (Z=+7e) (40). Unlike α-hemolysin, the vestibule 
domain is not present in aerolysin. Thus aerolysin has a greater effective length, which 
enabled the wild-type pore to resolve individual short oligonucleotides that are 2 to 10 
bases long without any modifications (39). Conductance studies revealed that the pore is 
slightly larger under positive applied voltage than under negative voltage, highlighting a 
geometric asymmetry because of a large extra-membranous vestibule domain (40). The 
channel is resistant to strong denaturing conditions, such as 1M Guanidinium-HCL (40). 
The conductance of Aerolysin under 1M KCl is 0.39 nS per pore (40). Membrane insertion 
occurred spontaneously when monomeric aerolysin was added to the chamber.  
2.4 CsgG (PDB: 4UV3) 
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CsgG exists as octameric or nonameric pore with a molecular weight of 244 kDa 
(Fig.1.2). It was discovered from outer membrane of Escherichia coli (41). As revealed in 
the crystal structure (41), the external dimension of the pore are 8.5×12 nm. The inner 
diameter of the pore is 4 nm and 3.5 at the cis and trans entrance. A 36-stranded β-barrel 
traverses the bilayer with a height of 3.5 nm and is linked to a cage-like vestibule in the 
periplasm with a height of 4 nm. The transmembrane and periplasmic domain are linked 
by a 0.9 nm channel constriction that formed by the side chains of residues Tyr51, Asn 55 
and Phe56. Functional and electrophysiological study showed that CsgG is a non-selective 
and ungated protein secretion channel. The conductance of CsgG under 1M KCl is 0.88 nS 
per pore (41).Because CsgG is an outer membrane channel, membrane insertion occurred 
spontaneously by adding CsgG to the cis chamber. In March 2016, Oxford Nanopore 
announced the identity of the R9 pore which is based on a CsgG pore and came from 
screening of 700 mutants. The company indicated the new R9 pore will be available for 
MinION and PromethION systems soon. 
2.5 Outer membrane protein G (OmpG) (PDB: open 2IWV and closed 2IWW) 
OmpG is a monomeric pore with a molecular weight of 35 kDa (Fig.1.2). It was 
discovered from Escherichia coli. The diameter of extracellular opening is 0.8 nm and the 
periplasmic side is 1.4 nm (42). The pore consists of 14 β-strands linked by 7 long loops 
on the extracellular side and 7 short turns on the periplasmic side. Structural studies showed 
that OmpG adopts an open and closed conformation at neutral pH 7.5 and acidic pH 5.6, 
respectively (43). Single channel assays revealed that wild-type OmpG gates 
spontaneously during applied potentials (42,44). However, the monomeric structure makes 
it straightforward for chemical or genetic modifications. Fluctuations in current signal 
11	  
	  
occurred due the presence of a flexible peptide loop inside the pore. Two approaches were 
employed to reduce the fluctuation by 95%: reduce the mobility of loop 6 by introducing a 
disulfide bond between the extracellular ends of strands β12 and β13; and optimize 
hydrogen bonding between strands β12 and β13 by deleting residue D215 (42). The 
conductance of OmpG monomeric wild-type and mutant under 1M KCl is 1.2 nS per pore 
in the fully open states (42). Membrane insertion occurred when OmpG protein with a 
potential of +150 mV applied to induce protein insertion. OmpG orients in the lipid bilayer 
with either the extracellular domain facing the cis or the trans chamber (42).  
2.6 Ferric hydroxamate uptake component A (FhuA) (PDB: 1BY5) 
FhuA is a monomeric protein with a molecular weight of 82 kD (Fig.1.2). It was 
derived from the outer membrane of E.coli. As revealed in crystal structure, the pore has 
an elliptical shape with a cross-section of 3.1×4.4 nm composed of 22-stranded β-barrel 
domain. The β strands lie anti-parallel to one another and exhibit an exceptional robustness 
(45). The FhuA pores retain their pore forming ability and robust attributes even after 
removal of one third of the amino acids (10). On the other hand, upon addition of two β-
strands to the protein primary sequence, it still maintains the pore forming ability with 
increased size (46). The channel diameter of the pore can be increased simply by doubling 
the amino acid sequence of the first two N-terminal β-strands resulting in 24 β-strands (46). 
The conductance of FhuA mutant ΔC/Δ 4L in which 160-residue cork domain and four 
long extracellular loops were deleted is ~4 nS under 1M KCl (47). Membrane insertion 
was aided by preparing FluA/Liposome (46).  
2.7 Cytolysin A (ClyA) (PDB: 2WCD) 
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ClyA is a dodecameric pore with a molecular weight of 408 kDa. It was discovered 
from Salmonella typhi. The geometry of this pore is still unknown, although the orthologue 
from E.coli has a crystal structure available (48). The dimension of ClyA nanopore 
constructed by homology modeling from the E.coli ClyA is 7.0 nm at its wider end and 3.8 
nm at its narrower end with a length of 13.0 nm (49). ClyA nanopore did not show gating 
significantly between +60 mV and -90 mV (49). Beyond this range of potentials, ClyA 
nanopore showed long lasting current blockades, which could be relieved by reversal of 
the applied voltage (49). The interior surface of ClyA is negative charged. The conductance 
of ClyA is 1.8 nS under 150 mM NaCl. Membrane insertion occurred by adding oligomeric 
ClyA to the cis chamber (49).    
2.8 PA63 (PDB: 1V36) 
PA63 is a heptameric pore with a molecular weight of 442 kDa (Fig.1.2). It is a 
fragment cleaved from protective antigen, which is a three component part of anthrax toxin 
secreted by Bacillus anthracis. After binding to the receptor, the full length PA83 (83 kDa) 
is cleaved by extracellular protease to generate PA63 (50). PA63 then self-assembles to form 
heptameric and octameric channels, which is a large cation-selective pore and inserts into 
the bilayer irreversibly (51,52). In the acidic endosomal environment, the oligomer of PA63 
undergoes dramatic structural changes, forming a mushroom-shaped ion channel. The 
crystal structure revealed that the dimension of PA63 is 12 nm at the ring-like cap domain, 
and 2.8 nm at the narrow end with 7 nm long cap and 10 nm long stem (53). When inserted 
into a lipid bilayer, fast flickering between open and closed states was found in this pore 
(52,54). This fluctuation disappeared after mutagenesis of F427A (55). PA63 conductance 
is sublinear in salt concentration from 0.1 to 2.5 M KCl, changing from ~80 pS to ~320 pS 
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correspondingly under 20 mV of applied voltage (52). Membrane insertion occurred by 
adding PA63 directly to the cis chamber. 
2.9 Viral protein channels: Phi29, SPP1, T3 and T4 connectors 
Phi29 connector (PDB:1H5W): Phi29 connector is a funnel shaped dodecameric 
channel with a molecular weight of 420 kDa (Fig.1.2). It is a key component of 
bacteriophage phi29 DNA packaging motor and acts as a pathway for the translocation of 
the genomic DNA. The diameter of the exterior part of the channel is 13.8 nm and 6.6 nm 
at the wide and narrow ends, respectively. The interior of the channel is 6 nm and 3.6 nm 
in diameter at the wide end and at the narrowest constriction, respectively. The channel is 
the first example of a nanopore that is neither an ion channel nor a membrane protein that 
has been inserted into a lipid bilyer(13). Phi29 connector displays robust properties and 
can withstand harsh mutagenesis, including site mutagenesis, insertion, and truncation. The 
membrane embedded channel is stable in a wide range of solution condition, including pH 
2-12, and ionic strengths of 0.1-3M (13,56). Unlike other membrane channels, the insertion 
of phi29 connector channel is not spontaneous, and it requires a two-step approach. The 
connector channel is first incorporated into lipid vesicles during reconstitution process and 
then the resulting proteoliposomes are fused with a planar lipid membrane(13). The 
conductance is uniform and the Current-Voltage trace is perfectly linear and is about 4.5 
nS under 1M KCl(13). 
 SPP1 (PDB:2JES): SPP1 connector is also a funnel shaped dodecameric channel 
which is from bacteriophage SPP1 that infects Bacillus subtilis. The connector has an 
overall diameter of 16 nm and a height of 10.5 nm. The narrowest constriction of the 
internal channel is ~3 nm (57,58). The conductance is about 4.1 nS under 1M KCl. Similar 
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to phi29 connector channel, the insertion of SPP1 connector channel is not spontaneous, 
and it requires a two-step approach (14). Under a scanning voltage (‒50 mV to +50 mV; 
2.2 mV/s), SPP1 displays a linear Current-Voltage (I-V) relationship without voltage 
gating. 
 T3:The T3 portal is a mixture of 12 and 13 subunits, depending on the protein 
expression conditions and other factors. The 12-mer version of the T3 portal is 14.9 nm in 
width, 8.5 nm in height and 3.7 nm in diameter for the internal channel (59). Under a 
scanning voltage (‒50 mV to +50 mV; 2.2 mV/s), T3 display a linear Current-Voltage (I-
V) relationship without voltage gating. T3 conductance distribution appeared as two peaks: 
2.6 nS and 3.9 nS. Like phi29 connector channel, the insertion of T3 connector channel is 
not spontaneous, and it requires a two-step approach (14). 
 T4: The T4 portal exists as a dodecameric ring that is 14 nm long and 7 nm wide, 
and an interior channel of ~3 nm in diameter (60). Unlike other membrane channels, the 
insertion of phi29 connector channel is not spontaneous, and it requires a two-step 
approach. Under a scanning voltage (‒50 mV to +50 mV; 2.2 mV/s), T4 display a linear 
Current-Voltage (I-V) relationship without voltage gating. The conductance is about 3 ns 
under 1M KCl. Like phi29 connector channel, the insertion of T4 connector channel is not 
spontaneous, and it requires a two-step approach (14). 
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Figure 1.2 Structure of commonly biological nanopore. Bottom view, intersection 
view and side view of phi29 connector channel, PA63, α-hemolysin, ClyA, MspA, FhuA, 
CsgG and SPP1.  
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Table 1.1. Structure basis of different protein nanopore (mw, structure 
feature, source, geometry) 
Name Source Oligomer 
State 
PDB ID Monomer 
MW(kDa) 
α-HL Staphylococcus 
aureus 
heptamer 3ANZ 33.2 
MspA Mycobacterium 
smegmatis 
octamer 1UUN 20 
Aerolysin Aeromonas 
hydrophila 
heptamer   47 
CsgG Escherichia coli octamer 4UV3 31 
OmpG Escherichia coli Monomer 2IWV(open) 
2IWW(closed) 
35 
FhuA Escherichia coli Monomer 1BY5 82 
GrA Bacillus Brevis dimer 1GRM,1MAG ~2 
ClyA Salmonellatyphi dodecamer 2WCD 34 
PA63 Bacillus anthracis heptamer 1V36 63 
Phi29 
connector 
Bacteriophage 
Phi29 
dodecamer 1H5W 35 
SPP1 
connector 
Bacteriophage 
SPP1 
dodecamer 2JES 56 
T3 
connector 
Bacteriophage T3 dodecamer   59 
T4 
connector 
Bacteriophage 
T4 
dodecamer   60 
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3.Engineering protein nanopores for DNA and RNA sequencing 
The capability of differentiating individual nucleotides of an intact DNA or RNA 
strand using protein nanopore is largely determined by the characteristics of the protein 
nanopore employed, and typically relies on nanopores with chemical modification or 
molecular motor incorporation. Without engineering, effective and high-resolution 
discrimination of nucleotides using wild-type biological nanopores remains elusive. The 
idea of using nanopores for DNA sequencing was proposed several decades ago since the 
landmark paper showing the translocation of single stranded DNA in α-hemolysin in 
1996(1). Several follow-up studies have shown that DNA/RNA homo-or co-polymers 
could be readily distinguished by α-hemolysin (22,61). Upon site directed mutagenesis at 
E111N and K147N, the electrostatic interactions between Glu-11 and Lys-147 was 
interrupted and resulted in enhanced blockade and better discrimination of poly(dA) and 
poly(dC) compared with wild-type (28). In addition, through immobilizing ssDNA via 
biotin-streptavidin conjugation on the channel entrance, three recognition sites were 
identified in this mutant that are located near the constriction, in the middle of the barrel, 
and the trans-entrance, respectively (28). In follow-up studies, the recognition capability 
was further enhanced by extensive mutagenesis of residues, including M113Y and 
M113W. The data showed that the mutant with substitution Gly residue actually reduced 
recognition ability (62). The authors suggested some additional substitution with unnatural 
amino acids, particularly those with aromatic side chain can further improve nucleobase 
recognition (62). With modification of the three recognition sites E111N/K147N/M113Y 
in α-hemolysin, epigenetic DNA modification, 5-methylcytosine and 5-
hydroxymethylcytosine, could be identified (63).  
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The next challenge was to slow down the translocation of DNA through α-
hemolysin. Several passive approaches have been tested including increasing viscosity 
(64), decreasing temperature (65), and adding organic salts (66), as well as more active 
approaches by attaching complementary DNA sequences (67), and enzyme (68). So far, 
incorporation of enzyme has turned out to be the most efficient way to slow down the DNA 
translocation speed in order to achieve DNA sequencing. Initial success was achieved by 
introducing T7 DNA polymerase into α-hemolysin. The blockage current signal caused by 
sequential nucleotide incorporation were recorded when DNA-polymerase complex was 
held at the entrance of the nanopore (68). However, the observed three sequential ionic 
current steps before the T7 DNA Polymerase dissociation from the template made this 
method impractical. Also the need for precise control of the replication rate and strand 
motion is critical for polymerase based DNA sequencing(69). Later, it was shown that 
phi29 DNA polymerase could overcome these weaknesses because it can maintain normal 
elongation and remain bound to the DNA template while captured in the nanopore (69) 
(Fig 1.2C). With phi29 DNA polymerase, α-hemolysin is able to ratchet DNA through the 
pore at 5-Å precision (69). By using an exonuclease approach, a DNA strand was digested 
and the released nucleotides were then captured and sensed with non-covalent adapter 
(4)(Fig 1.3B). Studies showed that individual RNA bases and even the modified bases can 
be distinguished by immobilizing ssRNA with α-hemolysin mutant E11N/K147N/M113Y 
(70). Later, the authors realized that direct RNA sequencing is feasible by introducing 
adaptor and polynucleotide phosphorylase (PNPase) which cut ssRNA in the 3’to 5’ 
direction processively and liberate rNDPs(71)(Fig 1.3E). In the study, kinetic parameters 
for rNDP identification was thoroughly compared and optimized in different mutant system 
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with different types of adaptor, including M113R-RL2 mutant of α-hemolysin with non-
covalently linked heptakis-(6-deoxy-6-amino)-β-cyclodextrin and heptakis-(6-deoxy-6-
guanidino)-β-cyclodextrin, and α-hemolysin-(N139Q)6(N139Q/L135C)1 with covalently 
linked heptakis-(6-deoxy-6-amino)-6- N-mono(2-pyridyl)dithiopropanoyl-β-cy-
clodextrin, thereby demonstrating that the mutant α-hemolysin with covalently attached 
cyclodextrin adapters is able to continuously identify RNA nucleotides (71).  
Recently, a different approach for DNA sequencing has been demonstrated that 
combines sequencing by synthesis (SBS) with α-hemolysin nanopore (72)( Fig 1.3D). The 
principle is that as DNA polymerase elongates the template, the incoming complementary-
tagged nucleotides is cleaved and the nucleotide can be differentiated by different-sized 
polymer tags (72). Unlike previous non-covalent polymerase, in this platform a single 
polymerase molecule is covalently attached to a single subunit of α-hemolysin using two 
strategies at an optimized distance that permits fast capture of the tag. First, the conjugation 
of Phi29 polymerase to α-hemolysin was accomplished using either SpyTag and 
SpyCatcher peptide domains, or chemical conjugation. By controlling the ratio of native 
and SpyTag monomer (1:6), α-hemolysin was assembled with only one SpyTag which was 
then covalently linked to Phi29 polymerase. Second, the conjugation of polymerase to α-
hemolysin was realized using Diels-Alder fast click chemical conjugation. Briefly, a Bst 
DNA polymerase molecule containing a single cysteine was reacted with excess of 6-
methyl-tetrazine-PEG4-maleimide in one tube, and an α-hemolysin heptamer containing a 
single cysteine at position 46 of only one monomer react with excess of trans-cyclooctene-
PEG3-maleimide in a separate tube. The polymerase-nanopore conjugate was obtained 
after mixing the two reactions after purification (72).       
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In MspA nanopore platform, the wild-type exhibits spontaneous blockades without 
ssDNA under an applied potential above 60 mV. To circumvent this problem, a mutant 
channel was generated whereby the negatively charged aspartate residues were replaced 
with asparagines in the constriction zone resulting in D90N/D91N/D93N mutant. Inspired 
by the unique structure of MspA (73,74), radical protein engineering rather than point 
mutagenesis was done in order to generate a sharper reading head and improve the 
resolution for base identification (75). In this study, truncated barrel mutant TBMΔ6 was 
generated based on NN mutant HL by PCR mutagenesis and ligation-free in vivo 
recombination that pair-wise removed amino acids from both β–strands (NN/Δ120-
125/Δ133-138). The resulting mutant TBMΔ6 has ~1.6 nm shortened barrel and showed a 
weakened R1 recognition site. Further mutagenesis Met113→Gly demonstrated sharpened 
base recognition. In another mutant of TBMΔ6 (Met113→Phe), it was found that positively 
charged β-cyclodextrin and am7βCD can reside in the interior of the mutant, thereby 
allowing continuous recognition of mononucleotides, which is a prerequisite for 
exonuclease sequencing. The capability of the mutant pore to discriminate between the 
four DNA and RNA nucleotides has been significantly improved compared to previous 
studies using the full-length RHL pore (71,76). The capability was measured as the 
products of the sequential differences (δ) between each residual current levels in the 
histograms. δ is defined as 0 when a pore that is unable to discriminate between all NMPs. 
In this study, δdNMP = 5.4 and δrNMP = 4.4 were obtained demonstrating a high differential 
capability (75).   
Several early studies have demonstrated that recognition of single nucleotide is 
possible with short ssDNA (77) without using DNA polymerase or exonuclease. To further 
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improve the MspA analysis capabilities in DNA sequencing, the authors further replaced 
negatively charged residues around the entrance and in the vestibule with positively 
charged residues, resulting in a mutant D90N/D91N/D93N/D118R/D134R/E139K. This 
mutant also had similar conductance as the first mutant, but is smaller than wild type. The 
studies demonstrate that proper substitution of charged residues provides a simple means 
to dramatically tailor the interaction between channel and analyte.    
By combining the reengineered MspA nanopore with the phi29 DNA polymerase, 
MspA nanopore is able to read DNA at single-nucleotide resolution (73)(Fig 1.3A). The 
same system is capable of detecting and mapping 5-methylcytosine and 5-
hydroxymethylcytosine, and proved to be extremely sensitive to abasic residues, which is 
one of the most common DNA lesions (78). Another study demonstrated that the 
engineered MspA nanopore with Phi29 DNA polymerase is capable of discriminating 
cytosine, hydroxymethylcytosine, and methylcytosine along individual DNA strands (79). 
To further push the platform into practical use for long reads of DNA sequence, Laszlo 
modified the platform by introducing two asymmetric adaptors: a cholesterol-tailed adaptor 
and a nicked, hairpin adaptor to the ends of linearized phi X174 dsDNA. Using this 
platform, they first constructed a current blockade map of all 256 four-nucleotide 
combinations because each four nucleotide combination has its own unique current 
fingerprint determined by this MspA platform. Using this map as a reference, this MspA 
platform is able to read 4500-bp sequence corresponding to natural DNA sequences (74). 
The current levels obtained from nanopore sequencing of the phi X 174 DNA strongly 
match the predicted current levels from quadromer map (r=0.9905, 95% confidence 
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bounds.). The authors speculated that the error can result from the shifts in the positioning 
of the DNA within the pore’s constriction and nucleotides outside of the quadromer.  
The speed of DNA translocation MspA is faster than α-hemolysin (8). The 
difference in translocation speed is possibly because of the difference between the widths 
of the channel regions flanking the narrowest constrictions. About 10-20 bases are highly 
confined in the constrict site and forced to interact with the channel wall in α-hemolysin. 
Whereas for MspA, there is only 2-4 bases in the constrict site. Another reason is the charge 
distribution within the constriction. The constrict site of α-hemolysin is formed by E111, 
K147, and M113. However, there are no charged residues in the constriction of MspA 
mutant, which may be responsible for the faster translocation speed in contrast to α-
hemolysin (8). A further arginine mutation in M1MspA slows DNA translocation by a 
factor of 10-30 without eliminating nucleotide specific current blockades (80). Recent 
studies have shown that by introducing a net positive charge on the interior surfaces, the 
rate of capture of DNA is improved in α-hemolysin and MspA (8,81). These results 
demonstrate that a better understanding of nanopore geometry and charge location is 
critical for improving their utility for sequencing and sensing. 
R9 pore, based on a CsgG pore as Oxford nanopore revealed the identity in March 
2016, is widely integrated into MinIon and PromethION systems for DNA and RNA 
sequencing and has replaced earlier used R6 pore. It is claimed that the accuracy in 1D 
reads (linear reads) and 2D (read both the template and complement strands) reads can be 
90% and 95% respectively (82).  
Oxford Nanopore Technologies: Although significant progress has been made in 
DNA sequencing in academic arena, Oxford Nanopore Technologies, is the first 
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commercial company to release a prototype in the market. MinION, the first product 
announced in 2012, measures electrical current changes as single strand of DNA pass 
through the pore. This device can be used to perform field-based work because it is portable 
(87g and flash drive like size) and can be operated through the USB port of a laptop 
computer. It contains up to 512 channels inside the chip and only needs 10pg-1ug DNA 
sample without PCR amplification. The flow cell input volume is 50-160ul with a lifetime 
up to 72 hours. Read length can be up to 200kb and run time can be 1 minute to 48 hours. 
The sequencing data can be analyzed in real time online or offline. The company launched 
MinION early access program in May 2014, which allow selected researchers to test this 
device for sequencing applications. Now it is available for purchase on its website starting 
for just $1000. The accuracy of sequencing was continually improved from June (66%), 
July (70%), October (78%) and November (85%) due to sequencing chemistry updates. In 
a recent study from Mark Akeson’s lab reports the sequencing of the 7.2 kb genome of 
M13mp18 with 99% of 2D MinION reads (83). The results demonstrate a single-nucleotide 
polymorphisms precision with accuracy up to 99% (84). Meanwhile, the company is 
developing various platforms, including PromethION and SmidgION. PromethION is a 
high throughput, tablet-sized instrument designed to allow the analysis of DNA, RNA, 
proteins or small molecules. It allows users to increase or decrease the flow cell numbers 
depending on experiment needs, and enable users to run an experiment until sufficient data, 
or sufficient quality has been met for high accuracy. SmidgION the same core technology 
as MinION and PromethION but will be designed for use with smartphones or other mobile 
with low power supply. It is designed to meet the broad needs of ield-based analyses such 
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as remote monitoring of pathogens in a breakout, the on-site analysis of environmental 
samples, and analysis of agricultural environments. 
Other Companies: Genia Technologies, a nanopore based sequencing company 
acquired by Roche in 2014, employed Nanotag sequencing approach. Briefly, four 
different length PEG-coumarin tags were attached to the terminal phosphate of 2’-
deoxyguanosine-5’-tetraphosphate first. Then, during the polymerase reaction as each 
modified nucleotide is incorporated into the growing strand, each tag is cleaved and enters 
a nanopore in order. Unique ionic current blockade of four different tags is determined and 
therefore decoding the sequencing of DNA (85). Recently, the company combined the 
approach, sequencing by synthesis (SBS), with α-hemolysin nanopore as discussed in 
section of Engineering protein nanopores for DNA and RNA sequencing. It has 
demonstrated high base resolution (72). Noblegen Biosciences, uses an approach that 
combines fluorescent labels and nanopores. In the approach, DNA is first converted into a 
longer ‘expanded synthetic representation’ (ESR) molecule through a process named 
‘circular DNA conversion’. Each expanded nucleotides has a corresponding color-coded 
‘beacon’. As the hybrid DNA passes through nanopores, beacon complex is pulled off and 
the fluorescent signal is detected (86). Illumina, as the dominant player in Next Generation 
Sequencing market, has also made substantial investments to develop their own nanopore 
technology since the commercialization  
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Figure 1.3 Strategies for sequencing DNA and RNA at single-nucleotide resolution 
using DNA polymerase or exonuclease. (A) MspA nanopore (73) (B) Proposed 
exonuclease based sequencing model (4). An exonuclease (pale blue) linked to the top of 
a nanopore by chemical linker or genetic fusion. After cleaved by exonuclease, the identity 
of individual nucleotide is determined sequentially by the level of the current blockaded. 
Single-channel recording from a-hemolysin with adapter and residual current histogram of 
nucleotide binding events showed the discrimination of dGMP, dTMP, dAMP and dCMP. 
(76) (C) Forward and reverse ratcheting of DNA through a-hemolysin equipped with phi29 
DNA polymerase (69). (D) Principle of nanopore DNA sequencing by syntheses (72). A 
DNA polymerase molecule is linked to an a-hemolysin. Template DNA and primer along 
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with the tagged nucleotide from a ternary complex with the polymerase. The tagged 
nucleotides is captured and detected sequentially with specific current blockades as they 
are incorporated into the growing DNA strands. (E) Nanopore RNA sequencing. A ssRNA 
oligonucleotide (circles) cleaved by polynucleotide phosphorylase (green) sequentially. 
The released nucleotides are detected by mutant a-hemolysin equipped with a cyclodextrin 
adapter(71). Figures reproduced with permissions from: (A) Ref. (73); (B) Ref. (4); (C) 
Ref. (69); (D) Ref. (72);(E) Ref. (71) 
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agreement with Oxford Nanopore has been terminated. It has licensed the MspA patent 
from the University of Alabama at Birmingham and University of Washington in 2013. 
However, there are no development progress released from the company so far.  
4. Engineering protein nanopore for single molecule sensing  
Another area that nanopore has been widely applied to is single molecule detection 
of ions, small molecules, macromolecules, and biopolymers. The sensitivity, specificity 
and stability of the sensing is largely determined by the characteristics of the nanopore 
employed, chemical modifications, and/or incorporation of probe or adaptor to the 
nanopore. Various approaches have been used to introduce probe, including site directed 
mutagenesis, fused expression, and covalent or non-covalent attachment of adaptors. 
Compared with solid state nanopore, one of the great advantages of protein pores is 
amenability for selective modification with various probes that can interact with individual 
target molecules with high sensitivity and selectivity. Normally, the probe has two states: 
occupied (by analyte) and unoccupied (vacant). The concentration of the analyte can be 
revealed by the occurrence frequency of the events, whereas the identity can be revealed 
by the characteristic binding and distinctive current signatures such as dwell time and 
amplitude of the events (87,88).  
Sensing directly using site directed mutagenesis  
Without specific amino acids modification, protein channels are generally able to 
detect quite a few analytes. However, by introducing artificial molecular recognition sites, 
it can greatly broaden the sensing spectrum of biological nanopores. A variety of 
engineered protein nanpore have been used to detect several ionic species. In one of the 
examples, four histidines were introduced at position 123, 125, 133, and 135 of α-
28	  
	  
hemolysin in which the side chains were projecting into the lumen. This mutant subunit 
was incorporated into a heteromeric pore composed of six wild-type α-hemolysin subunits 
and one mutant α-hemolysin (WT64H1). The mutant heteromer form was able to detect the 
concentrations of two or more divalent metal ions simultaneously (89,90).  
Guan generated a series of mutants on Met 113 in α-hemolysin, including 
Met113Phe7, Met113Tyr7, Met113Tyr7, Met113His7, Met113Asp7, Met113Glu7, 
Met113Arg7, Met113Lys7, Met113Pro7, and Met113Val7, which can be classified into 
three groups: aromatic (Phe,Trp,Tyr), hydrophobic (Met, Pro, Val), and charged(Asp, Glu, 
Arg, Lys). The data showed that TNT can only be detected by three aromatic Met113 
mutants (91). In phi29 connector nanopore system, ethane, thymine and benzene with 
reactive thioester moieties were clearly distinguished upon binding with the cysteine group 
mutated from lysine 234 (15)(Fig 1.6 D,E). DNA translocation with one-way property has 
also been reported in this system (Fig 1.6 A-C) (56,92).  
Recently, it is reported that the fingerprints of various peptides were detected by 
phi29 motor channel (Fig.1.5). The peptides were distinguished by current blockage 
percentage and current signatures. In addition, the oligomeric states of peptides can be 
studied in real time (93). One way traffic of peptide translocation has been observed in 
both SPP1 and phi29 motor channel (94) (Fig.1.5). Also, the study found that the 
orientation of the insertion into lipid membrane was governed by the hydrophobicity and 
hydrophilicity of the termini of the protein channel (Fig.1.5).   
Sensing via probes introduced through covalent linker  
Engineering of nanopore using probes at specific locations can greatly increase the 
possibilities for stochastic sensing of macromolecules. Normally, protein is too large to 
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pass or fit inside the pore, so it is necessary to couple external binding modules to generate 
a signal. One end of a single 3.4 kDa polyethylene glycol chain was attached to the mutant 
S106C monomer. A biotin molecule was tethered covalently to the free end of the polymer. 
Nanomolar concentration of streptavidin was detected through reversible capture observed 
as changes in ionic current. This approach might be modified for detecting a wide variety 
of protein ligands (95).  
By hybridization to an oligonucleotide, which is attached to N17C monomer 
through a disulfide bond near the cis-entrance of α-hemolysin, a DNA aptamer can be 
attached to α-hemolysin and used for quantification of nanomolar concentrations of 
thrombin (96). Using a similar strategy, Howorka covalently attached a single DNA 
oligonucleotide to a mutant single cysteine residue at position 17 of α-hemolysin, located 
at the cis-opening of the pore. This modification enable the system to detect 
complementary strands (67). This platform was further exploited to detect a resistance 
conferring mutation in an HIV-derived DNA sequence (67). 
A similar strategy was used in ClyA nanopore which is wide enough to sample and 
differentiate large analyte. In the study, DNA aptamers containing an activated thiol group, 
were conjugated to ClyA monomers comprising of a single cysteine at position 110. The 
results showed that the engineered ClyA nanopore is able to distinguish human and bovine 
thrombin despite 86% sequence similarities (49). Howorka reported an approach to study 
the kinetics of binding of tetravalent lectin to a ligand engineered pore (97). In the report, 
thiopyridyl derivative of the disaccharide Gal-β-1,3-GalNac, a ligand for protein lectin, 
was coupled to a cysteine residue engineered at position 9, located at the narrower part of 
the cis-opening of the α-hemolysin pore. The engineered subunit was then assembled into 
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three different heptamers containing one, two and seven modified subunits (97). In another 
study, a ligand, PKIP5-24, was tethered to trans-entrance of α-hemolysin at position 
Cysteine 129 through disulfide bond, to study the binding interaction of cAMP-dependent 
protein kinase to the ligand (98).    
Beside the study of macromolecule interaction, a reversible covalent chemistry was 
also studied using protein nanopores. In one study, a single photolabile carbamate group 
3,4-dimethoxy-6-nitrobenzylcarbamate group was tethered to the interior wall at 
Thr117Cys of α-hemolysin. Upon UV light illumination the fragments of protecting group, 
the intermediates of the decomposition can be detected because the current depend on the 
shape, size, and polarity of the reactants tethered within the pore (99). At the same mutant 
position, Loudwig attached azobenzene via disulfide bond and studied the light induced 
isomerisation at the single molecule level (100). Chemical transformation such as covalent 
bond formation was also studied using this strategy (101).  
 
31	  
	  
 
Figure 1.4 Main approaches for biological nanopore sensing and detection. (A) 
Illustration of the three main approaches to engineer a-hemolysin pores for sensing. Left: 
The sensor element is introduced by genetic modification within the lumen which is able 
to bind metal ions. Middle: Enhancing host-guest interaction by equipping with a ring-
shaped molecular adaptors inside the lumen such as cyclodextrins. Right: A ligand is 
covalent attached poly (ethylene glycol) chain at one end, which is linked to the lumen of 
the pore at the other end (87). (B) Left: a genetically engineered a-hemolysin fused with a 
single protein kinase inhibitor peptide (PKIP), which is able to bind cAMP-dependent 
protein kinase and cause current blockade change. Transmembrane β-barrel (yellow) and 
the PKIP sequence (orange and green) (102). Middle: schematic of the wild type a-
hemolysin displaying β-cyclodextrin resident in the lumen of the channel (103). Right: a 
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disaccharide natural ligand is covalently linked to modified a-hemolysin to stochastically 
detect the interaction with the tetrameric lectin (97). (C) A thrombin aptamer is linked to 
a-hemolysin by hybridization to an oligonucleotide that is attached to a single cysteine 
residue near the mouth of the pore through a disulfide bond. From the current blockade 
level, the interactions of thrombin and aptamer can be detected (96). Figures reproduced 
with permissions from: (A) Ref. (87); (B) Ref. (97,102,103); (C) Ref. (96). 
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Figure 1.5 Application of phi29 connector nanopore for peptide sensing. (A) 
Schematic of peptide translocation through phi29 connector nanopore and the Ni-NTA-
nanogold binding assay for determining the orientation of C-His phi29 connector nanopore. 
(B) The orientation of phi29 connector nanopore when inserted into lipid membrane is 
governed by hydrophobicity at the N- or C-terminus. (C) Current trace and blockade of 
different peptides when passing through phi29 connector nanopore (93,94). Figures 
reproduced with permissions from (93,94). 
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Sensing via probes introduced through fusion protein expression  
Introducing new functions through fused expression of the encoded genetic 
sequence of the proteins is always challenging, because the folding of proteins cannot be 
reliably predicted. One method often adopted by nature to solve this challenge is combining 
evolutionarily preserved regions of proteins with generally independent protein domains. 
In one study, the functional elements of co-chaperonin GroES was introduced to α-
hemolysin nanopore to study the interaction with GroEL at the single molecule level. The 
fused flexible loops of GroES with α-hemolysin showed correct folding with enzymatic 
activity mediating GroEL-assisted protein folding efficiently as native GroES (104). In a 
recent study, epithelial cell adhesion molecule (EpCAM) peptide was co-expressed with 
phi29 connector nanopore at the C-terminus (105). The binding of EpCAM antibodies 
sequentially to each peptide probe induced stepwise blocks in current. The docking and 
undocking kinetics of probe-antibody can be analyzed in real time at single molecule level 
by the distinctive current signatures. Importantly, the signal of EpCAM antibody can be 
distinguished from the background events such as serum or nonspecific antibody. The 
results demonstrate the feasibility of generating a highly sensitive platform for detecting 
antibodies at extremely low concentrations in the presence of contaminants (14) (Fig 1.6F).  
Sensing with non-covalent adaptors 
A variety of sensing functions can be achieved by introducing an adapter into 
protein nanopore. Lodging of an adapter in the lumen of protein nanopores can reduce the 
current flow and provide host-guest interactions. One class of adapters are ring-shaped 
molecules, which can lodge inside a pore and mediate the binding of small analytes. β-
cyclodextrin, which has a hydrophobic interior cavity and a hydrophilic exterior, is the 
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most commonly used adapter for biosensing. Gu first introduced β-cyclodextrins to wild-
type α-hemolysin non-covalently (106). Due to weak interactions, the residence time of β-
cyclodextrins on the pore is only several hundred microseconds, although it can be 
extended to several milliseconds by adjusting the pH and trans-membrane potential. This 
largely limits widespread applications as stochastic biosensors. The possible lodging sites 
of β-cyclodextrins at the internal end of the β-barrel were further enhanced by site directed 
mutagenesis at Met 113, Lys 147 and Glu 111. The binding affinity was thereby increased 
104 fold compared to wild type, resulting in prolonged residence time of about tens of 
seconds (103,107). Organic ligands, such as 1-adamantanecarboxylic acid, 2-
adamantanamine, or drugs imipramine and promethazine reversibly bound to the β-
yclodextrin adapter and resulted in analyte characteristic blockade fingerprints (107).  
The advantages of non-covalent adaptors have been further demonstrated by 
sensing individual nucleotide analytes. The adapter heptakis-(6-deoxy-6-amino)-β-
cyclodextrin was lodged into the α-hemolysin pore, and reversible binding of adaptor to 
2’-deoxyribonucleoside 5’-monophosphaes resulted in distinct current levels for each base 
(108). Another protein nanopore that employed β-cyclodextrin is outer membrane protein 
G. Heptakis-(6-deoxy-6-amino)-β-cyclodextrin, a positively charged β-cyclodextrin 
derivative, was introduced to double mutant OmpG (42). 
Sensing with covalent adaptors 
Covalently attachment of cyclodextrin was achieved by Wu and his colleagues by 
linking engineered Met 113 cys to cyclodextrin-propionate through disulfide bond (109). 
One of the advantages of covalent attachment is that the adapter cannot dissociate, which 
will not cause gaps during stochastic detection. This is especially useful for single molecule 
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exonuclease DNA sequencing which require the continuous presence of a molecular 
adapter. Another advantage is that the orientation of the adapter will be fixed which will 
allow analytes to bind through only one of the entrances to the cyclodextrin cavity (109). 
In a more recent study, the unlabeled nucleoside 5’-mono-phosphate molecules can be 
continuously identified by a covalently attached adapter with accuracies averaging 99.8% 
(76). Methylated cytosine could also be differentiated from the four standard bases (76).  
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Figure 1.6 Application of phi29 connector nanopore for dsDNA, single chemical and 
antibody detection. (A) Current trace of dsDNA translocation through phi29 connector 
nanopore (92). (B) Histogram of current blockade and dwell time of dsDNA(56,92). (C) 
One-way traffic of dsDNA translocation through a single phi29 connector nanopore under 
a ramping potential and switching polarity. DNA is mixed in both cis- and trans-chambers 
(110). (D) Schematic of conjugation of chemical ligands to the channel wall caused the 
reduction of channel size as reflected by current blockade (15). (E) Analysis of current 
blockage events for the binding of thioester groups containing ethane, thymine, and 
benzene (15). (F) Schematic of phi29 connector nanopore for colon cancer specific 
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antibody detection (14). (G) Histogram of current blockage events caused by nonspecific 
antibody with or without EpCAM antibody, and diluted serum with or without 
EpCAM(14). Figures reproduced with permissions from: (A-B) Ref. (56,92);(C) Ref. 
(110);(D-E) Ref. (15);(F-G) Ref. (14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39	  
	  
Changing oligomeric state and capability of forming channel  
In biological system, pores normally evolve with fixed stoichiometry. Control of 
subunit stoichiometry is critical to tailor protein nanopore for various applications since it 
can change the constriction zone size, and later the physical and chemical properties of the 
protein channel. In the studies of α-hemolysin, either homo- or hetero-heptameric form 
have been achieved. Because both N- and C-termini of single subunit of α-hemolysin are 
on the same side of the lipid membrane, the N- and C-termini of two subunits was linked 
to form dimer to generate an even number of subunits of α-hemolysin. Interestingly, the 
dimer still can assemble into heptamer form indicating that one of more subunits are 
expelled from the central pore (111). In MspA, the oligomer state was changed by 
connecting two mutated M1-MspA subunit through a liker ranging from 17-62 amino acids 
in length. A follow-up study demonstrated that the linked dimer formed functional channels 
with similar property as M1 MspA, which is suitable for DNA sequencing (35). 
In phi29 connector channel, it has been reported that by deleting a loop in the central 
part of the channel, the conductance of the channel can be reduced about 40% compared 
to the wild-type indicating that the oligomeric state has been changed. The resulting mutant 
can be used to distinguished ssRNA and ssDNA (112). It is believed that the connector 
channel exists with fixed oligomeric states, which is mostly dodecamers, (113), the 
stoichiometry of the connector of different bacteriophages has been reported to vary from 
11-mer to a 14-mer in vitro following ectopic expression and assembly, and heterogeneous 
population have also been found (59,114-117). It has been reported that the conformational 
changes occurring in specific segments, such as helix α6 of the tunnel loop and the crown 
region may be responsible for the different oligomeric states (57). 
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CONCLUSIONS: 
In the last two decade, biological nanopores-based technology has made significant 
progress for DNA sequencing and single molecule sensing, and is well positioned to bring 
a revolution to medical diagnostics and DNA sequencing market. To date, several protein 
channels such as α-hemolysin, MspA, Aerolysin, FluA, Omp G, and viral connectors 
Phi29, SPP1, T3 and T4 have been successfully used for incredibly versatile applications 
including detection of small molecules, macromolecule, polymers, polypeptides, as well as 
DNA and RNA. Although significant progress has been made, several challenges still 
remains in nanopore area, such as limited knowledge of structure-function of protein 
channel, and the analytes that can be analyzed by available nanopores are still limited 
because different analytes requires unique protein nanopore with different shape, size, 
physical dimensions and hydrophilic/hydrophobic properties. Therefore, it still requires 
continuous improvement of current available nanopore and exploration new channels and 
pores by protein engineering.  
For DNA /RNA sequencing, several key challenges that used be the bottlenecks in 
nanopore-based sequencing has been resolved such as the ultra-fast translocation of DNA 
through nanopore, spatial resolution and platform stability. However, the accuracy which 
is still low compared with current sequencing technologies. Many efforts are still needed 
to optimize the platform by using protein engineering, large scale screening, exploration 
new nanopore and improving the algorithmic in the future. 
A wide range of analytes ranging from ions, small molecules, macromolecules, to 
biopolymers have been detected successfully using nanopore. However, most of these 
development were still in the laboratory stage. How to improve the sensitivity, stability and 
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specificity especially using clinical sample which is often in the presence of many 
impurities is still the major bottleneck to transform nanopore for clinical use. Also, more 
effort should be made to explore detectable capability such as protein and peptide 
sequencing, protein structure and folding studies. 
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Chapter 2: Engineered Nanopore of Phi29 DNA-Packaging Motor for 
Real-Time Detection of Single Colon Cancer Specific Antibody in 
Serum 
This chapter was reproduced (with some modification) with permission from Wang S, 
Haque F, Rychahou P, Evers BM, and Guo P. “Engineered Nanopore of Phi29 DNA-
Packaging Motor for Real-Time Detection of Single Colon Cancer Specific Antibody in 
Serum.” ACS Nano, 2013 Nov 26;7(11):9814-22. DOI: 10.1021/nn404435v. Copyright 
2014 American Chemical Society.  
INTRODUCTION: 
In biological systems, transmembrane and biomotor channels play critical roles in 
all aspects of life, such as regulating the traffic of macromolecules and ions into and out of 
nuclei, organelles, and cells, segregating chromosomes, and translocating and transporting 
single- or double-stranded DNA.(118-122) In bacterial virus phi29, with the aid of an ATP-
driven motor, double-stranded DNA (dsDNA) viruses package their genome into pre-
formed protein shells called procapsids.(123,124) The motor consists of the protein enzyme 
gp16, which functions as a part of ATPase, six copies of packaging RNA (pRNA),(125-
128) and a central protein core called connector.(129,130) The connector is composed of 
12 protein subunits that encircle to form a dodecameric channel, which enables dsDNA to 
translocate into the procapsid of the phage and exit during maturation and infection.(123-
126) The crystal structure of the phi29 connector was determined at atomic resolution.(130) 
The ring is 13.8 nm at its wide end and 6.6 nm at its narrow end. The internal channel is 6 
nm in diameter at the wide end and 3.6 nm in diameter at the narrow end (Fig. 2.1C, D, E). 
The wider end (C-terminal) of the connector is located within the capsid, while the narrow 
end (N-terminal) partially protrudes out of the capsid.  
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Recently, the connector channel has been incorporated into lipid bilayers to serve 
as a membrane-embedded nanopore with robust properties. This system has shown 
sensitive and unique conductance signatures when DNA or ions pass through the 
channel.(13,56) The channel conductance was uniform, as demonstrated by a perfectly 
correlated linear response to applied voltage. The connector channel is stable under a wide 
range of solution conditions, including a pH range of 2 to 12 and different salt species and 
concentrations.(56) A one-way traffic property for dsDNA translocation from the N-
terminal to the C-terminal with a valve mechanism for DNA packaging has also been 
observed.(110) The connector channel has shown three discrete steps, gating at higher 
trans-membrane potentials associated with conformational change in the channel 
subunits.(131) The availability of the crystal structure of this connector channel has 
enabled explicit engineering with atomic precision for added functionality. Recently, a 
reengineered connector channel with a reduced channel size has shown the capability to 
discriminate single strand DNA or RNA from double strand(112). By selectively 
functionalizing a probe in the interior of the channel, single chemicals with reactive 
thioesters or maleimide groups can be identified based on their distinct fingerprints(15). 
Procedures for large-scale production and purification of the connector have already been 
developed.(13,132-136) Taken together, these features make the connector channel an 
ideal system for sensing and diagnostic applications. 
Nanopore-based sensory techniques have been extensively studied for the detection 
of a variety of macromolecules and chemicals based on modulations of the individual 
current blockage events.(4,17,137-140) Engineered transmembrane channels with various 
probes are capable of stochastic detection by observing (in real time) the individual binding 
44	  
	  
events between single ligands and receptors with high selectivity and 
sensitivity.(87,141,142) The unique current signatures and characteristic binding can 
reveal the identity and concentration of the target analyte.(143,144) Moreover, the dynamic 
interaction between the analyte and the probes can be studied in real-time at high resolution 
by using single channel conduction assays. One advantage of the single molecule 
techniques is the low limit of detection, which is ideal for the early detection of biomarkers 
that exist in ultra-low concentrations, making it possible to diagnose specific diseases at an 
earlier (i.e., asymptomatic) stage.  
In this study, we introduced an Epithelial Cell Adhesion Molecule peptide 
(EpCAM) that was 18 amino acids long as a probe into the C-terminal of each subunit (Fig. 
2.1A, B). EpCAM is a cell surface molecule known to be overexpressed by the majority of 
human epithelial carcinomas, including prostate, breast, colorectal and head and neck 
cancers.(145-151) We incorporated this reengineered channel into a lipid bilayer and 
characterized its conductance properties. We then detected the binding of EpCAM 
antibody at a single molecule level in nano-molar concentrations based on the unique 
current signatures. The docking and undocking kinetics of antibody-probe interactions 
enabled us to determine the Kd. To further test the detection capability of this engineered 
phi29 channel and push nanopore techniques for clinical utilization, we performed the 
EpCAM antibody detection in the presence of either non-specific antibody or diluted 
serum. We showed that the EpCAM antibody can be distinguished from the background 
events that are present. Our results demonstrate the feasibility of reengineering the 
connector channels with a wide range of probes for medical diagnostic applications in the 
future. 
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MATERIALS AND METHODS: 
Materials 
The phospholipid 1,2-diphytanoyl-sn-glycerol-3-phosphocholine (DPhPC) was 
purchased from Avanti Polar Lipids, Inc. Organic solvents (n-decane and chloroform) were 
obtained from Fisher Scientific, Inc. and TEDIA, Inc., respectively. The EpCAM antibody 
was purchased from Abcam Company. All other reagents, if not specified, were purchased 
from Sigma-Aldrich, Inc. 
Serum sample preparation 
Male athymic NCr nude mice between 6-8 weeks of age were acquired from 
Taconic (Hudson, NY) and kept in an animal house with 12 hour of light and dark cycled. 
Food and water was given ad libitum. Blood serum was collected from vena cava and 
allowed to clot for 30 min at room temperature. The clotted material was removed by 
centrifugation at 2000 rpm for 10 min in a refrigerated centrifuge. Hemolytic material was 
not observed. The sera obtained from the blood samples were frozen immediately without 
any further treatment in liquid nitrogen and stored at -80°C until further use. 
Cloning and Purification of the Engineered EpCAM Phi29 Connector Protein 
The construction of the plasmid containing the gp-10 gene and the expression and 
purification of the phi29 connector have been reported previously.(132,134) The new 
plasmid was constructed first by introducing an EpCAM probe 
(ELKHKAREKPYDSKSLRT) to the C-terminal of the connector channel, just 
downstream of gp-10 gene; a His tag was inserted into the N-terminal for purification. The 
newly constructed clone was transformed into HMS174 (DE3) E. coli bacteria. The 
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successfully transformed bacteria were cultured in 10 mL Luria-Bertani medium overnight 
at 37°C. These cultured bacteria were transferred to 500 mL of fresh LB medium. When 
OD600 reached 0.5-0.6, 0.5 mM IPTG was added to the cultured medium to induce protein 
expression. The bacteria were collected after 3 hr, post-centrifugation induction. A French 
press was used to lyse the bacterial wall, and the protein and other components were 
differentiated by centrifugation.  
An Ni-NTA His bind resin with a His tag was applied to purify the mutant protein. 
Briefly, 2 ml of regenerated His resin was packed into a column First.  The supernatant 
differentiated by centrifugation was loaded into the column. The column was then washed 
with washing buffer to remove any contaminant proteins. The His-tagged mutated gp10 
protein was eluted using elution buffer that contained 500 mM imidazole.  
Preparation of Lipid Vesicles Containing EpCAM Engineered Connector Channels. 
The incorporation of connectors into liposomes has been reported previously.(13) 
Briefly, 1 mL of 1 mg/mL DPhPC in chloroform was poured in a round-bottomed flask. 
The chloroform in DPhPC lipid was removed under vacuum. Then, the lipid film that 
formed was rehydrated with EpCAM engineered connector channel buffer, which 
contained 1M NaCl, 10 mM Tris/pH7.9, and 250 mM sucrose to bud off vesicles into the 
solution. The unilammellar lipid vesicles were generated by passing the lipid solution 
through a 400 nm polycarbonate membrane filter.  
Incorporation of the Connector Channel into a Planar Bilayer Lipid Membrane 
The method of inserting the connector with reconstituted liposomes into a lipid 
bilayer has been reported previously.(13) Briefly, a Teflon film partition (aperture 200 µm 
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in diameter) was used to separate a bilayer lipid membrane chamber  into cis and trans-
compartments. The aperture was painted two times with 0.5 uL of 3% (w/v) DPhPC n-
decane solution, and the two compartments were filled with conducting buffer (0.2 M 
NaCl, 1mM HEPES, pH 7.4). After the formation of the lipid bilayer on the aperture, the 
lipid/connector complexes were added to the chamber and allowed to fuse with the planar 
lipid bilayer.   
Single Channel Conduction Assays for Each Membrane Inserted Connector Channels 
 A pair of Ag/AgCl electrodes was connected directly into the cis and trans-
compartments to measure the current traces across the lipid bilayer membrane. The current 
trace was recorded using an Axopatch 200B patch clamp amplifier coupled with the Axon 
DigiData 1322A analog-digital converter (Axon Instruments) or the BLM workstation 
(Warner Instruments). All voltages reported were those of the trans-compartment. Data 
was low band-pass filtered at a frequency of 1 kHz, and acquired at a sampling frequency 
of 10-100 kHz. The Patch clamp 9.1 software (Axon Instruments) was used to collect the 
data, and the software Origin Pro 8.0 was used to analyze all the data.  
 All antibody binding experiments were conducted under 0.2M NaCl, 1 mM HEPES 
pH 7.4 buffer. EpCAM antibody was added only after the definite insertion of EpCAM 
engineered connector channels in the lipid bilayer membrane. For selectivity of the 
EpCAM connector channel study, mouse serum was diluted to 100-fold using the 
electrolyte buffer; 10 ng/ul of non-specific antibody was pre-mixed with the buffer. Then 
EpCAM antibody was added only after the addition of EpCAM engineered connector 
channels. The current traces were recorded over a period of 1 to 2 hrs, and all the 
experiments were repeated at least three times. 
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RESULTS: 
Incorporation of the EpCAM Peptide to the C-terminal End of the Connector  
To facilitate connector purification, an N-terminal His tag was inserted just 
upstream of the gp-10 connector gene. An EpCAM peptide (18 amino acids in length) was 
inserted downstream of the gp-10 connector channel gene at the C-terminal end. To provide 
end flexibility, a linker with 6 glycines was included between the gp-10 connector and the 
EpCAM peptide probe (Fig. 2.1A-B). The reengineered connectors were purified to 
homogeneity and run on an SDS-PAGE gel (Fig. 2.1F) with wild-type and C-His tagged 
connectors as controls. The molecular weights of C-His tagged and N-His-C-EpCAM 
modified connector subunits were 36.7 kDa and 40.6 kDa, respectively. After purification, 
the reengineered channels with the EpCAM probe assembled into a ring composed of 12 
evenly spaced probes in the same plane within the dodecameric connector channel. In 
addition, we compared the conductance of EpCAM connector channels and C-his 
connector channels under the same buffer conditions. The similar conductance and 
histogram distribution that was noted indicates they have similar cross-sectional areas. The 
accessibility and specificity of EpCAM probes on the engineered connector was further 
verified by Western blot assays (Fig. 2.1G). Compared with the controls (EpCAM peptide, 
C-His connector and bovine serum albumin [BSA]), the EpCAM antibody was observed 
to bind specifically to the EpCAM reengineered connector. The intensity of the band 
corresponding to EpCAM Ab/EpCAM connector complex increased as the concentration 
of EpCAM engineered connector channel was increased from 0.15 µg to 1.2 µg (Fig. 
2.1G).   
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Figure 2.1: Illustration of the phi29 connector channel structure. (A) Structure of one 
subunit showing the location of the EpCAM probe (red). (B) Construction of the modified 
gp10 gene by insertion of His tag at the N-terminus, 6-Gly linker and EpCAM probe at the 
C-terminus. (C) Top view and (D) side view. (E) Section view of the phi29 connector 
channel showing the size and location of the EpCAM probe (red) and incorporation of the 
EpCAM receptor into the phi29 DNA packaging motor channel. (F) Molecular weight of 
wild type, C-His and N-His C-EpCAM connector on 10% SDS-PAGE. (G) Demonstration 
of the accessibility and specificity of EpCAM probe in the C-terminal of the phi29 
connector channel by Far Western blot. 
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Characterization of the Membrane-Embedded EpCAM Reengineered Connector 
Channels  
The EpCAM engineered connector channel was incorporated into planar lipid 
membranes in two steps, as previously described.(13) The first step was to incorporate the 
connector into liposomes, followed by insertion into planar lipid membranes via vesicle 
fusion of liposome/connector complexes, to form a membrane-embedded nanopore.(13,56) 
The insertion of the EpCAM engineered connector channels generated a stepwise increase 
of the current, as shown in the continuous current trace (Fig. 2.2A). The insertion of 
EpCAM probe at the C-terminus did not affect the membrane signal stability, voltage 
gating properties, membrane durability, or the membrane insertion efficiency of the 
connector channel. The current step size of the EpCAM engineered connector channels 
was homogeneous (Fig. 2.2C), and the channels showed equal conductance under both 
positive and negative transmembrane voltages. The average current jump was 55± 6 pA 
(0.74±0.09 nS) in 0.2 M NaCl, 1 mM HEPES, pH 7.4. Conductance was derived at specific, 
constant holding potentials (+75 mV or -75 mV) after the phi29 connector channel was 
incorporated into a lipid membrane and was calculated as the ratio of the current jump 
induced by a discrete step to the applied voltage. Occasionally, two connector channels 
were observed to insert simultaneously, as demonstrated by a conductance of 1.43±0.03 nS 
(Fig. 2.2C). Under the same buffer condition, the reengineered N-his C-EpCAM connector 
channel showed similar conductance with C-his one (0.76±0.08 nS), indicating the 
modification did not change the conductance and size of the channel (Fig 2.2 C). The 
uniformity of this engineered connector channel was further demonstrated by applying 
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ramping voltage which showed a nearly linear I-V relationship without exhibiting any 
voltage gating phenomenon under the reported conditions of ±100 mV (Fig. 2.2B).  
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Figure 2.2. Characterization of membrane-embedded EpCAM engineered phi29 
connector channels. (A) Continuous current trace showing multiple insertions of EpCAM 
reengineered connector channels into planar lipid bilayer. (B) Current voltage trace under 
a ramping voltage of -100 to 100 mV. (C) Conductance comparison of N-his C-EpCAM 
and C-his connector channel under the same buffer condition 75 mV.  
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Real-Time Sensing of EpCAM Antibody Interactions with EpCAM Reengineered 
Connector Channels  
Under 0.2 M NaCl, 1 mM HEPES, pH 7.4 buffer solution, a series of blocking 
events was observed in the presence of EpCAM antibody in the cis-chamber. The binding 
of an EpCAM antibody to each probe induced stepwise blocks (every block represented a 
single molecule binding) in current (Fig 2.3B-C), with a corresponding decrease in 
conductance because of the physical blocking of the channel. One parameter used to 
characterize the binding events was the current blockage percentage, which represents the 
difference between the open connector channel and the current after EpCAM antibody 
binding. Current blockage percentage was calculated as follows: size of current blockage 
resulting from binding one EpCAM antibody to one connector channel divided by step size 
of the current for one connector insertion.  
Two classes of current blockage signals were observed. The first class represented 
transient binding events, which may be induced by the temporary and reversible binding 
of an EpCAM antibody with the probe, shown as recoverable blockage signals (Fig 2.3B). 
The second class was the permanent binding events (Fig 2.3C), which represented tight 
binding between the EpCAM probe on the connector and the antibody. This second class 
was observed as discrete stepwise augmentation of current blockage. Both classes of 
blockage events resulted in ~20 pA reduction in current, which corresponds to 36.8±1.8% 
for transient events and 34.7±2.6% for permanent binding events (Fig 2.4A-B). The current 
blockage was not caused by the translocation of antibody, because the molecular weight of 
antibody, about 150 kDa, was too large to pass through the connector channel (487 kDa). 
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In addition, given the dimensions of an antibody (14.2 nm ×8.5 nm × 3.8 nm)(152), it is 
highly unlikely to translocate through the 3.6 nm connector channel. 
Another parameter to characterize the antibody and probe interaction is the dwell 
time (τ), which is the duration of a blockage event. The transient events, on average, had a 
dwell time of ~30 ms, implying that the transient events are indeed caused by the temporary 
binding of the EpCAM antibody to the probe on the connector, rather than the unlikely 
event of translocation through the pore. The dwell time distribution can be used to 
determine the docking and undocking kinetics of antibody-probe interactions. The binding 
time of the antibody to the probe is defined as τoff, whereas the duration time between two 
consecutive blockade events is defined as τon. Figure 5 represents a statistical analysis of 
the binding kinetics based on more than one thousand transient binding events. The 
histograms of τon and τoff were fitted with a single-exponential distribution function, 
where is the time constant indicating the association and dissociation processes. The 
frequencies of association   and dissociation   are shown as a function of antibody 
concentration [P] (Fig 2.5C-D). The association rate constant   was determined using the 
equation  . The association frequency increases linearly with antibody concentration (Fig. 
5C). The dissociation rate constant  was determined using the equation  . The dissociation 
frequency was independent of antibody concentration (Fig 2.5D). Based on the two rate 
constants, the equilibrium dissociation constant   was (5.8±3.4) ×10-7 M. 
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Figure 2.3. Real time sensing of EpCAM antibody interactions with EpCAM 
engineered phi29 connector channels. (A) Before addition of EpCAM antibody. (B) 
Transient binding events. (C) Permanent binding events.  
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Figure 2.4. Analysis of current blockage induced by EpCAM probe/antibody 
interaction. (A) Histograms of transient current blockage. (B) Histograms of permanent 
current blockage events. (C) Scatter of dwell time versus current blockage. 
 
 
 
57	  
	  
 
Figure 2.5. Kinetic studies of EpCAM probe/antibody interaction based on transient 
dwell time events. (A) Event histograms of current time traces τon, which is the time 
between two consecutive binding events. (B) Event histograms of current time traces τoff, 
which is the dwell time. (C) Frequency of association as a function of antibody 
concentration [P], which is linear fit to , yielding the association rate Kon. 
(D) Frequency of association as a function of antibody concentration [P], which is a 
constant fit to offoff k=)(1/t
! , yielding the dissociation rate Koff.  
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Selectivity of the EpCAM Probe for EpCAM Antibody in the Presence of Serum and 
Protein Impurities  
In almost all clinical scenarios, a patient’s sample will not be highly purified and, 
most likely, will consist of serum protein and other components (e.g., a blood sample). To 
investigate how the impurities in the sample affect EpCAM antibody detection and to 
further push nanopore sensing techniques into the realm of clinical disease diagnosis, we 
performed the following experiments: 1) EpCAM antibody in the presence of a high 
concentration of non-specific antibody; and 2) EpCAM antibody in the presence of diluted 
serum sample (Fig 2.6). As the concentration of non-specific antibodies increased to 10 
ng/ul, the current signal caused by non-specific interaction between the antibody and probe 
or channel was noted, and the current blockage distribution was determined to be 
28.8±2.7%. Under the same buffer conditions containing a high concentration of non-
specific antibody, we increased the EpCAM concentration to 4 ng/ul and noted another 
blockage peak, centered at 38.9±2.3%. The position of this new blockage peak was 
consistent with the previous blockage distribution of EpCAM antibody using the same 
buffer without non-specific antibody, indicating that this new blockage peak was caused 
by EpCAM interaction with the probe.  
Serum sample is commonly used in clinical diagnosis. However, most diagnosis 
studies using nanopore techniques, particulally protein nanopore, have not been conducted 
in the presence of serum due to the fragile nature of the lipid bilayer, which greatly impedes 
the pace of applying the nanopore technique for clinical use. Here, we used 100-fold diluted 
serum with an electrolyte buffer that can maintain its stability for at least one hour. We first 
tested the noise level caused by impurity in the diluted sample in the presence of diluted 
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serum only. The current blockage distribution was 30.4±1.5 %. As the concentration of 
EpCAM antibody increased to 4 ng/ul, a new blockage peak was noted centered on 
37.4±1.9 %, which corresponds to the previous EpCAM antibody blockage distribution. 
This data demonstrates that phi29 nanopore channels are capable of detecting individual 
molecular species in a complex mixture and can discriminate the signal from background 
events that are present due to the serum component.  
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Figure 2.6: EpCAM antibody detection in the presence of high concentration of non-
specific antibody and diluted serum. (A) Histogram of current blockage events caused 
by high concentration of non-specific antibody. (B) Histogram of current blockage events 
caused by high concentration of non-specific antibody with EpCAM Ab. (C) Histogram of 
current blockage events caused by diluted serum. (D) Histogram of current blockage events 
caused by diluted serum with EpCAM Ab.  
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DISCUSSION  
The first step for detection of proteins or small molecules is to capture the analyte 
and gather evidence, such as fingerprints. Many sensing, detection, and diagostic 
techniques, such as biotin/streptavidin interactions, and microarray-based technologies, 
have been well developed, but also have a disadvantage: it is not possible to detect a single 
substrate molecule, regardless of the strength of the antibody affinity. In addition, the 
background noise will override the specific signal from the antigen/antibody complex at 
very low concentrations. Recent nanopore studies have detected single protein molecules 
and distinguished them from the other molecules with engineeredparticular 
receptor.(96,153,154) Compared to conventional protein detection methods, nanopore-
based technology has the advantage of label-free, real-time sensing of individual molecules 
and in the presence of contaminants, all at a relatively low cost.  
For the kinetic and thermodynamic studies of macromolecular interactions, 
nanopore offers several advantages over traditional methods, such as surface Plasmon 
resonance (SPR) and capillary electrophoresis (CE). For example, steric hindrance due to 
crowding of the binding sites occurs on the surface of an SPR chip, but does not occur in 
the nanopore setup.(155) Moreover, the molecular flow rate may interfere with the 
accuracy of the measurement in SPR and CE. For example, an analyte can rebind to the 
surface of a chip if the flow rate is too slow in SPR, and this can complicate the kinetic 
analysis.(155) 
EpCAM is a transmembrane glycoprotein, which is highly overexpressed on many 
cancers. Its ectodomains can be released at levels ranging from 2-78 ng/ml  into sera of 
cancer patients.(156) Studies have shown that the expression of EpCAM depends on many 
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factors, such as tumor type, disease stage, tumor microenvironment and host anti-tumor 
immunity.(157) In this study, we incorporated an EpCAM peptide into the phi29 connector 
channel. A linker with 6-glycines was included between the gp-10 connector and the 
EpCAM peptide probe to provide end flexibility. EpCAM antibody binding was then 
detected at nano-molar concentrations using single-channel conduction assays. The 
distinctive current signatures enabled us to analyze the docking and undocking kinetics of 
antibody-probe interactions and determine the Kd. However, one critical problem limits 
the application of nanopores for kinetic studies of single molecules: it is time-consuming 
to study high-affinity interactions. For example, if the ligand remains bound to the receptor 
for several minutes, several hours may be needed to acquire enough unbinding events. In 
our study, we observed two classes of current blockage signals: permanent binding and 
transient binding. For transient blockage events, dwell time lasts tens of milliseconds, 
suggesting weak interactions between EpCAM antibody and the probe. Therefore, in the 
kinetic assessment, we based our analysis on the transient events data, which may account 
for the relatively low Kd (10-7 M) compared with the value of typical EpCAM antibodies 
(10-8- 10-11 M). Here, the modification on the C-terminal end of phi29 connector channel 
has not changed the conductance and channel size compared with C-his connector channel 
(Fig. 2C). The channel has a diameter of 3.6 nm at the narrow end (N-terminal) and 6 nm 
at the wide end (C-terminal). Our small peptide antigen was fused to the wide end (C-
terminal). Fusing the small peptide antigen to the wide end did not change the conductance 
of the channel, since conductance is determined by the narrowest end, which was not 
affected by the C-terminal conjugation with a peptide that sticks out.  
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Most recent research on applying nanopore techniques for sensing and detection 
has been performed under ideal conditions using only pure analytes in the presence of the 
detection system. However, in the majority of clinical samples, the trace analyte is always 
present in combination with a large proportion of impurities or in serum. To further test the 
detection capability of this engineered phi29 channel and push nanopore techniques for 
clinical utilization, we performed the EpCAM antibody detection in the presence of either 
high concentration non-specific antibody or diluted serum. We showed that the EpCAM 
antibody can be distinguished from the background events presented as either non-specific 
antibody or serum components. 
CONCLUSIONS: 
Our results demonstrate the feasibility of reengineering the phi29 connector 
channel for sensing probe-antibody interactions in real-time using single channel 
conduction assays. The Kd of EpCAM has been calculated from the docking and 
undocking kinetics of Ab-probe interactions. The signal of EpCAM antibody can be 
discriminated from the background events in the presence of non-specific antibody or 
serum. Our novel findings will inspire future studies to construct more sophisticated 
connector sensor systems capable of recognizing multiple analytes from ions, small 
molecules, peptides and small proteins.  
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Chapter 3: Three-step Channel Conformational Changes Common to 
DNA Packaging Motors of Bacterial Viruses T3, T4, SPP1, and Phi29 
This chapter was reproduced (with some modification) with permission from Wang S, Ji 
Z, Yan E, Haque Fand Guo P. “Three-step Channel Conformational Changes Common to 
DNA Packaging Motors of Bacterial Viruses T3, T4, SPP1, and Phi29” Virology. 2016 
May 12. pii: S0042-6822(16)30073-3. doi: 10.1016/j.virol.2016.04.015. Copyright 2016 
Elsevier Inc. 
INTRODUCTION: 
DNA translocation motors are ubiquitous in living systems (158). During 
replication, the genome of double stranded DNA (dsDNA) viruses is packaged into a 
preformed protein shell, referred to as the procapsid. This process requires a powerful, 
ATP-driven packaging motor. In many viruses, the motor involves a pair of DNA 
packaging proteins, a smaller auxiliary subunit is usually a protein oligomer that comes 
into contact with the dsDNA, and a larger one is an ATPase protein (159). In many dsDNA 
bacterial viruses and herpes viruses, the motor docks onto a structure called the portal or 
connector. Structural studies have shown that the portals in herpes virus and a variety of 
tailed bacterial viruses, such as phi29, SPP1, T4, and T3, share a similar cone-shaped 
dodecameric structure (Fig 3.1), even though their primary sequences do not display any 
significant homology.  
In bacterial virus phi29, the portal is comprised of 12 protein subunits assembled 
into a truncated cone structure, with a diameter of 13.8 nm and 6.6 nm at the wide and 
narrow ends, respectively. The interior channel is 3.6 nm at the narrowest constriction 
(130). In SPP1, the assembled channel is a 13-mer structure, and the narrowest part is 2.77 
nm in diameter (Fig 3.1) (57,58). The T4 portal exists as a dodecameric ring that is 14 nm 
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long and 7 nm wide, and an interior channel of ~3 nm in diameter (60). The T3 portal is a 
mixture of 12 and 13 subunits, depending on the protein expression conditions and other 
factors. The 12-mer version of the T3 portal is 14.9 nm in width, 8.5 nm in height and 3.7 
nm in diameter for the internal channel (59).  
The portal plays a critical role in genome packaging and the ejection process. 
During assembly, it acts as a docking point for the motor ATPase and a conduit for dsDNA 
entry. After DNA packaging, the portal serves as a binding site for the tail components in 
order to complete virion assembly. When bacterial viruses initiate infection, DNA is 
ejected through the coaxial channel of the portal and tail channel into the host cell. In the 
bacterial virus SPP1, the portal protein undergoes a concerted structural conformational 
change during its interaction with DNA (160). Recent results obtained using the 
membrane-embedded phi29 portal connector demonstrated that dsDNA moves in only one 
direction, i.e. from the external narrow end to the internal wide end, referred to as “one-
way traffic”(110). Biological data from the ATPase studies combined with single molecule 
studies led to the conclusion that the DNA translocation of bacterial virus phi29 takes place 
via a “Push through a one-way valve” (161) or a “One-way revolution mechanism” in order 
to package DNA (162-164).  The meaning of “Push” is in accordance with the findings in 
T4 that indicate a compression mechanism (165-167). Since the channels act like a one-
way valve, an obvious question arises: how is dsDNA ejected during the course of infection 
if the channel is a one-way inward valve? Earlier studies demonstrated that the portal 
exercises conformational changes during the respective DNA packaging and ejection 
processes. For example, in the phi29 portal, conformational changes are inducible by DNA, 
pRNA or divalent metal ions (112,168,169). It was also reported that, the channel loop of 
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phi29 DNA packaging motor plays an important function near the end of packaging to 
retain the DNA (170). Cryo-EM imaging also revealed conformational changes of the 
connector in infectious virion in comparison with the free connector in vitro (171). 
However, none of these studies have yet shown conformational changes at the single 
molecule level. 
 Nanopore-based single molecule detection has attracted considerable attention 
across a number of disciplines due to its versatility of application. Examples include the 
detection of small molecules of chemicals, nucleotides, drugs and enantiomers, as well as 
larger polymers, such as PEG, polypeptides, RNA and DNA. One novel application was 
the insertion of the phi29 portal into an artificial membrane in order to serve as a robust 
nanopore (13) for single molecule detection (15) and disease diagnosis (105). The phi29 
portal channel displays voltage-induced channel gating as well as a one-way traffic for 
dsDNA translocation during the course of DNA packaging (110,131,172). It has been 
reported that interaction of ligand with the C-terminal of the connector leads to the 
conformational changes in the phi29 connector channel, resulting in an altered current 
signal that have been utilized for detecting single antibodies as a very sensitive method for 
disease diagnosis (105). Here we report that the discrete conformational changes in the 
channel are common in bacterial viruses T3, T4, SPP1 and phi29. These observations 
support the idea that the one-way inbound channel is transformed into an outbound channel 
in preparation for DNA ejection (173).  
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Figure 3.1: Structures of phi29, SPP1, and T4 and T3 portal channels. Top view, side 
view and single subunit of phi29 (A); SPP1 (B); and T4 (C) portal protein. Phi29 gp10 
PDB: 1FOU; SPP1 gp6 PDB: 2JES;T4 gp20 PDB: 3JA7. 
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MATERIALS AND METHODS: 
Materials and reagents 
 The phospholipid, 1,2-diphytanoyl-sn glycerol-3-phosphocholine (DPhPC) 
(Avanti Polar Lipids), n-Decane (Fisher), chloroform (TEDIA) were used as instructed by 
the vendors. If not specified, other reagents were purchased from Sigma. His binding 
buffer: 15% glycerol, 0.5 M NaCl, 5 mM Imidazole, 10 mM ATP, 50 mM Tris-Cl, pH 8.0. 
His washing buffer: 15% glycerol, 500 mM NaCl, 50 mM Imidazole, 10 mM ATP, 50 mM 
Tris-HCl, pH 8.0. His elution buffer: 15% glycerol, 500 mM NaCl, 500 mM Imidazole, 50 
mM ATP, 50 mM Tris-Cl, pH 8.0.  
Expression and purification of phi29, SPP1, T3, and T4 portals 
 The expression and purification of phi29 portal followed the procedure reported 
previously (13,174). Gene 6 encoding for SPP1 portal protein gp6, and gene 8 encoding 
for T3 portal protein gp8 were synthesized (Genescript) and then cloned separately into 
pET3c vector between the NdeI and BamHI sites. A 6×His-tag was inserted at the C-
terminus for purification. The resulting plasmids harboring gene 6 or gene 8 were 
transformed separately into E. Coli BL21(DE3) and a single colony was cultured in 10 mL 
Luria-Bertani (LB) medium overnight at 37 °C. The culture was transferred to 1 L of fresh 
LB medium and 0.5 mM IPTG was added to induce protein expression after the OD600 
reached 0.5-0.6. After 3 hrs, cells were collected by centrifugation at 6000×rpm for 15 min 
and the pellet was resuspended in His Binding Buffer. Bacteria were lysed by passing 
through a French press and the clear supernatant was collected after centrifugation at 
12000×rpm for 20 min and then loaded onto a His•Bind® Resin Column. SPP1 or T3 portal 
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protein was eluted from the His•Bind® Resin Column with His Elution buffer after several 
rounds of washing.  
 Gene 20 encoding for the T4 portal protein gp20 was amplified from the T4 genome 
and cloned into pET3c at the NdeI and BamHI sites (Keyclone). A 6×His-tag was 
introduced at the C-terminus for purification. Due to its hydrophobicity, T4 portal had a 
tendency to easily aggregate. Protein expression and purification methods were therefore 
modified (175). Plasmid pET3c harboring gene 20 was transformed into E.Coli 
HMS174(DE3) and a single colony was cultured in 10 ml LB medium overnight at 37 °C. 
The culture was transferred to 1 L of fresh LB medium and cultured until OD600 reached 
0.5-0.6. IPTG (0.5 mM final concentration) was then added to induce T4 portal protein 
expression. The culture was transferred to 18 °C and incubation continued overnight. Cells 
were harvested by centrifugation at 6000×rpm for 15 min and resuspended in His binding 
buffer. Cells were lysed by passing through a French press. The cell pellet was collected 
after centrifugation at 12000×rpm for 20 min and resuspended in His binding buffer 
containing 1% N-Lauroylsarcosine for 20 min. The supernatant was collected after 
centrifugation at 12000×rpm for 1 hr and loaded to His•Bind® Resin Column and eluted 
after several rounds of washing. The purity of all final protein products was verified by 
10% SDS-PAGE gel. 
Preparation of liposomes containing the phi29, SPP1, T4 and T3 portals 
 All portal/liposome complexes were prepared following our reported procedures 
(13,174). Briefly, 0.5 mL of 1 mg/mL DPhPC in chloroform was added to a round bottom 
flask and the chloroform was evaporated under vacuum using a Rotary Evaporator (Buchi). 
The dried lipid film was rehydrated with 0.5 mL of portal protein solution containing 250 
71	  
	  
mM sucrose. Unilamellar lipid vesicles were obtained by extruding the lipid suspension 
through a 400 nm polycarbonate membrane filter (Avanti Polar Lipids). 
Portal insertion into planar lipid bilayer  
 Procedures for inserting the portal connector into a lipid bilayer have been reported 
previously (13,136,174). Briefly, a thin Teflon partition with an aperture of 200 µm was 
used to separate the Bilayer Lipid Membrane (BLM) chamber into cis- and trans-
compartments. The aperture was pre-painted with 5% (wt/vol) DPhPC in hexane solution. 
The cis and trans- chambers were filled with conducting buffer, 1 M KCl, 5 mM HEPES, 
pH 7.8. Then 20% (wt/vol) DPhPC in decane solution was used to form a planar lipid 
bilayer. After confirming the formation of the lipid bilayer, the portal/liposome complexes 
were added to the cis-chamber to fuse with the planar lipid bilayer to form the membrane 
embedded nanopore.  
Electrophysiological measurements 
The stochastic nanopore sensing technique is based on the principle of the classical Coulter 
Counter or the ‘resistive-pulse’ technique (176). The portal is located in an electrochemical 
chamber, which is separated into two compartments filled with conducting buffers. Under 
an applied voltage, ions passing through the portal channel will generate current in pico-
Ampere (pA) scale (137). When a charged molecule passes through the channel, it will 
generate transient current blockages due to volumetric exclusion of ions from the pore. 
Various parameters, such as the event dwell time, current amplitude, and unique electrical 
signature of the current blockages can be used either individually or in combination for 
detection. 
72	  
	  
A pair of Ag/AgCl electrodes inserted into both compartments was used to measure the 
current traces across the BLM. The current trace was recorded using an Axopatch 200B 
patch clamp amplifier coupled with the BLM workstation (Warner Instruments) or the 
Axon DigiData 1440A analog-digital converter (Axon Instruments). All voltages reported 
were those of the trans-compartment. Data was low band-pass filtered at a frequency of 5 
kHz or 1 kHz and acquired at a sampling frequency of 2-20 KHz. PClamp 9.1 software 
(Axon Instruments) was used to collect the data, and Origin Pro 8.0 was used for data 
analysis. 
RESULTS: 
Cloning, expression and purification of the portals of phi29, SPP1, T4 and T3 
 Following the strategy previously used for the purification of phi29 portal 
(13,136,174), a 6×glycine linker was introduced between the portal coding sequence and 
6×His-tag to provide end flexibility. Both SPP1 and T3 portals were soluble in the 
cytoplasm of E. Coli. The T4 portal showed a strong tendency to aggregate due to its 
hydrophobic nature. Therefore, 1% N-Lauroylsarcosine surfactant was added to the 
purification buffer to solubilize the protein (175). After purification to homogeneity, 
proteins were analyzed by 10% SDS-PAGE. The single protein subunit of the phi29, SPP1, 
T4 and T3 portals corresponded to their predicted sizes of 36 kDa, 56 kDa, 60 kDa and 59 
kDa, respectively (Supp. Fig 3. 1).  
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Supplemental Figure 3.1 Coomasie-blue stained 10% SDS-PAGE showing the molecular 
weight differences of single subunit of phi29 (36 kDa), SPP1 (56 kDa), T4 (60 kDa) and 
T3 (59 kDa) portal channels. 
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Insertion of portal channels into lipid membrane for determining channel size using 
conductance measurements  
To incorporate phi29, SPP1, T4 and T3 portal proteins into a planar lipid bilayer, 
we adopted a two-step procedure described previously (13): reconstitution of the portal in 
liposomes, followed by fusion of protein/liposomes with the planar lipid bilayer to form 
the membrane-embedded portal channel. Experiments were carried out using 1 M KCl, 5 
mM HEPES, pH 7.8 conduction buffer and 50 mV applied potential. Each current jump 
represented the insertion of one channel into the lipid bilayer. Since the fusion of the portal 
protein/liposome with the planar lipid bilayer is a random event, the time between 
independent insertion events varies. Fig. 3.2A-D provides representative results for the 
portals of the four phages. The channel conductance (derived from the ratio of measured 
current jump to the applied voltage) of phi29, SPP1 and T4 was determined to be 4.52±0.33 
nS, 4.10±0.22 nS, and 3.03±0.37 nS, respectively (Fig 3.2E-G). T3 conductance 
distribution appeared as two peaks: 2.65±0.31 nS and 3.90±0.38 nS (Fig 3.2H). The 
conductance values correspond to the respective pore sizes of phi29, SPP1, T3 and T4 
portal channels (Fig. 3.2). 
 Under a scanning voltage (‒50 mV to +50 mV; 2.2 mV/s), the phi29, SPP1, T4 and 
T3 portal channels all display a linear Current-Voltage (I-V) relationship without voltage 
gating  (Fig 3.2I-L). When 100 mV was applied, the phi29, T4 and T3 portal channels 
remained stable, but the SPP1 portal channel started to gate (data not shown). In addition, 
the SPP1 portal channel had a stronger tendency to close the gate under negative voltages 
compared to positive potentials (data not shown).  
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Figure 3.2: Representative current traces showing insertion of phi29 (A), SPP1 (B), T4 
(C) and T3 (D) portal channels into planar lipid membrane. Applied voltage: +50 mV. 
Histogram showing the conductance distribution of phi29 (E), SPP1 (F), T4 (G) and T3 
(H) portal channels. Applied voltage: +50 mV. Current-Voltage trace under a ramping 
potential (‒50 mV to +50 mV; 2.2 mV/s) for phi29 (single channel) (I), SPPI (two 
channels) (J), T4 (one channel) (K) and T3 (three channels) (L) portals. Conducting 
buffer: 1 M KCl, 5 mM HEPES, pH 7.8 
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Three step gating of phi29, SPP1, T4 and T3 portal channels  
 When a higher voltage (>100 mV) was applied, three distinct steps of 
conformational changes of the channel were observed in all four portal channels. 
Conformational changes were reflected by a reduction in electrical current of 33%, 66% 
and 99% for the first, second, and third step, respectively (Fig 3.3). Three discrete step 
gating of the phi29, SPP1, T4 and T3 portal channels were observed under an applied 
positive voltage of +150 mV, +150 mV, +170 mV and +150 mV, respectively (Fig 3.3A-
D). Similar phenomena were observed under negative voltages of ‒125 mV, ‒100 mV, ‒
175 mV and ‒125 mV for the four portals, respectively (Fig 3.3E-H). These are the 
minimum voltages required for channel gating.  
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Figure 3.3: Three step gating associated with conformational changes of phi29 (A), SPP1 
(B), T4 (C), and T3 (D) portal channel under positive trans-membrane voltages. Three 
steps gating associated with conformational changes of phi29 (E), SPP1 (F), T4 (G) and 
T3 (H) portal channels under negative trans-membrane voltages. 
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DISCUSSION 
The polymorphism of portal complexes assembled from overexpressed genes of 
bacterial viruses has been reported for many years. Although it is believed that the T4 and 
SPP1 portals exist as dodecamers in their biologically active state , the stoichiometry of 
the overexpressed portal gene products in different bacterial viruses has been reported to 
vary from 11-mer to 14-mer (114,115,117,177,178). Several studies revealed that the T3 
portal structure is a mixed population of 12 and 13 subunits (59). The diverse distribution 
of conductance for phi29, SPP1, T4, and T3 portals might represent various oligomeric 
states in these portal complexes. This is reflected by the two major peaks observed in the 
T3 conductance distribution (Fig 3.2H).  
It has been shown that all portal channels of dsDNA bacterial viruses display a left-
handed channel wall configuration to facilitate the one-way traffic of dsDNA into 
procapsid by a revolution mechanism without rotation (110,121,162,164). The one-way 
valve mechanism is consistent with the findings of genome gating in SPP1, albeit gating 
mechanism proposed by these authors is based on the analysis of the channel structure after 
the completion of DNA packaging instead of during translocation (160). The finding of the 
“push through a one-way valve” mechanism (158,161) raises the question of how dsDNA 
is ejected during infection if the channel only permits dsDNA to translocate in one 
direction. We believe that during dsDNA translocation, the interaction of the dsDNA with 
the channel wall and the procapsid component next to the portal will trigger conformational 
changes of the portal. Therefore, the left-handed portal channel, which facilitates dsDNA 
advancement in one direction, will transition to a neutral or right-handed configuration in 
three steps to facilitate DNA ejection after DNA packaging is complete (164).  
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Such conformational changes of portal proteins, as proposed above for ejection of 
the packaged dsDNA, have previously been proposed (131,134,171). Portal gate closing 
has been reported in SPP1 (179) and speculated in T4(60). Moreover, it was reported that 
SPP1 portal undergoes a concerted reorganization of the structural elements of its central 
channel during interaction with DNA. Structural rearrangements and gate closing were 
reported to associate with protein-protein and protein-DNA interactions, and a diaphragm-
like mechanism for channel reduction and gate closing has been proposed (160). The 
changes with discrete steps might be considered as the analogy of a camera lens by 
suggesting discrete f-stops, like f4.5, f8, f16, f32. However, the diaphragm proposal is 
difficult to reconcile with the data implying a right-handed twisting of the connector 
structure while comparing the free connector with the structure of the connector in the 
DNA-filled virion (171). The finding of the common discrete 3-step conformational change 
in T3, T4, SPP1 and phi29 implies a universal property of all portals. It is possible that the 
three gating steps may also correspond to the quantized steps of partial genome ejection 
observed in T3 (180), and the partial packaging intermediates observed in phi29 (181). 
CONCLUSIONS 
 The motor channel of T3, SPP1, T4, and phi29 all display three discrete steps of 
voltage gating resulting from channel conformational changes. The result suggests that the 
one way inbound channel during the DNA packaging process is transformed into an 
outbound channel prepared for DNA ejection during the host infection. 
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Chapter 4: Channel of SPP1 DNA Packaging Motor for Real Time 
Kinetic Analysis of Peptide States 
This chapter (with some modification) is in submission at Biomaterials. Special thanks to 
Zhengyi Zhao for help and assistance in preparation of data for figures 4.4 and Dr. Zhi 
Zhou for help in preparation of data for figure 4.6 and Table 4.1. 
INTRODUCTION: 
Living systems contain wide varieties of nanomachines with diverse structures and 
functions. The ingenious design of viral DNA packaging motors and their intriguing 
mechanism of action has provoked a wide range of interests among scientists in many 
different areas(158,182,183). Tailed bacteriophages are viruses that infect and reproduce 
within a bacterium, and widely exist in the biosphere. The portal protein is one of the 
essential components of the viral packaging motors with a turbine-like shape(184,185). 
SPP1 is a dsDNA phage that infects Bacillus subtilis. The DNA packaging motor of SPP1 
consists of a terminase composed of small (gp1) and large (gp2) subunits, portal protein 
gp6, and a two head completion proteins gp15 and gp16(179,186) that powers the 
encapsulation of 45.9 kbp genomic DNA(177). The central core of the SPP1 motor is a 
portal channel, termed connector, which is composed of 12 or 13 copies of protein gp6 
(57,186). Explicit engineering of the SPP1 portal protein is possible due to its available 
crystal structure (57,58). The connector has an overall diameter of 16 nm and a height of 
10.5 nm. The narrowest constriction of the internal channel is ~3 nm (Fig. 1)(57,58).  
Nanopore technology has recently emerged as a real-time and high-throughput 
single molecule detection method, holding great potential for sensing a wide range of 
82	  
	  
analytes, molecular diagnostics and DNA sequencing applications(4,16,17,138,139,187-
190). Solid state nanopores generated by microfabrication generally have less reproducible 
pore sizes and lack chemical and location selectivity(137,191). Protein nanopores 
harvested in bacteria are homogenous in size and can be functionalized with probes, but 
commonly used nanopores such as α-hemolysin, MspA, and aerolysin have an internal 
channel diameter of only ~1.3 nm(40,73,192). Larger protein pores such as ClyA(193) and 
FhuA(194) are being developed for single molecule analysis. In search for alternative 
larger sized channels, we previously developed membrane-embedded phi29 motor 
channels(13,56,174) for single molecule sensing of nucleic acids(13,56,110,112,172,195), 
chemicals(15), or binding assays of antibody based on channel conformational 
change(105,110). Herein, we engineered the SPP1 motor channel and inserted it into a lipid 
bilayer to serve as a new nanopore platform for detecting the translocation and dynamics 
of peptide oligomeric states at single molecule level.  
Elucidating the oligomeric states of proteins and peptides is critical for 
understanding their biological functions. A wide range of biophysical methods, such as X-
ray crystallography, NMR, Circular Dichroism, Dual Polarization Interferometry, and 
Mass Spectrometry have been used to investigate folding and dynamic structural changes 
of peptides and proteins. However, these methods require expensive instrumentation and 
specialized labor. Nanopores offer an attractive alternative as they are intrinsically single 
molecule in nature requiring ultra-low sample volumes, are label free, amplification free, 
and function using a simple detection process requiring no specialized expertise. While the 
translocation of DNA and RNA have been studied extensively in biological 
nanopores(73,137,138,196), studies on translocation of protein or peptides are beginning 
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to emerge(197-201). The proteome can be an accurate and direct indicator of current health 
status of patients(202). For example, early diagnosis and monitoring the changes of 
amyloid-β peptide and α-synuclein are critical for the management of Alzheimer’s and 
Parkinson’s disease(203).  
Several studies demonstrating peptide translocation using nanopores have been 
published(9,49,204-215), but quantitative analysis and translocation validation remain 
challenging, since there is no technique available for amplifying protein substrates as in 
DNA or RNA qualification using PCR. The availability of only trace amounts of peptide 
or protein for analysis after translocation is far beyond the sensitivity threshold of classical 
protein detection methods.  In this report, we used single molecule fluorescence 
microscopy to validate data obtained from resistive pulse technique to quantitatively study 
peptide translocation through SPP1 connectors and elucidate the structural conformations 
of peptides at the single molecule level. Due to the available of crystal structure, this new 
nanopore can be explicitly engineered via site directed mutagenesis, and has the potential 
to be applied for biomarker analysis, early disease diagnosis and even protein sequencing. 
MATERIALS AND METHODS: 
Materials  
 The phospholipid 1, 2-diphytanoyl-sn-glycerol-3-phosphocholine (DPhPC) was 
obtained from Avanti Polar Lipids, Inc. Organic solvents (n-decane and chloroform) were 
purchased from Fisher Scientific, Inc. and TEDIA, Inc., respectively. TAT peptide was 
custom-ordered from GenScript, Inc. All other reagents were purchased from Sigma or 
Fisher, if not specified.  
Cloning and Purification of the SPP1 connector 
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 Gene gp6 encoding SPP1 portal was synthesized and cloned into PET3 vector 
between NhdeI and BamHI by GenScript, Inc. His-tag was inserted into the C-terminal of 
the connector for purification. Then the plasmid was transformed into BL21 (DE3) for 
expression and purification. The purification procedure has been described 
previously(13,174). Briefly, the transformed bacteria were cultured in 10 mL LB medium 
overnight at 37°C. The bacteria were transferred to 1 L of fresh LB medium. When the 
OD600 reached ~0.5-0.6, 5 mM IPTG was added to the medium to induce protein 
expression. The bacteria were collected by centrifugation after 3 hours continuous culture. 
Bacteria was lysed by passing through French press. Lysed cell was separated by 
centrifugation and supernatant containing expressed protein was collected. The supernatant 
was purified with Nickel affinity chromatography (Novagen) (133). His Binding Buffer 
(15% glycerol, 0.5 M NaCl, 5 mM Imidazole, 10 mM ATP, 50 mM Tris-HCl, pH 8.0), and 
the cleared lysate was loaded onto a His•Bind® Resin Column and washed with His 
Washing Buffer (15% glycerol, 0.5 M NaCl, 50 mM Imidazole, 50 mM Tris-HCl, pH 8.0). 
The His-tagged connector was eluted by His Elution Buffer (15% glycerol, 0.5 M NaCl, 
0.5 M Imidazole, 50 mM Tris-HCl, pH 8.0). The purified connector from chromatography 
was further purified by a 15-35% glycerol gradient ultracentrifugation at 35K for 2 hrs. 
Before incorporating into liposomes, the purified connector was dialyzed against buffer 
(0.5 M NaCl, 50 mM Tris-HCl, pH 8.0) to remove excess glycerol. 
Insertion of the connector into planar lipid bilayer 
The protocol for the incorporation of connectors into lipid bilayer has been 
reported(13,56,110,131,174). Briefly, 150 µL of 10 mg/mL DPhPC lipids in chloroform 
was placed in a round bottomed flask and the chloroform was evaporated under vacuum 
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using a rotary evaporator (Buchi). The dehydrated lipid film was then rehydrated with 300 
µL buffer containing 250 mM sucrose and purified connectors (0.5-1 mg/mL). The 
suspension was thoroughly vortexed and maintained at 45 °C (above the phase transition 
temperature of DPhPC) followed by extrusion through 400 nm polycarbonate membranes 
(Avanti Polar Lipids) to generate uniform sized liposome/connector complexes.  
Planar bilayer lipid membranes (BLMs) were generated in a BCH-1A horizontal 
BLM cell (Eastern Scientific). A Teflon partition with a 200 µm aperture was placed in the 
apparatus to separate the BLM cell into cis- (top) and trans- (bottom) compartments. The 
aperture was pre-painted with 0.5 µL of 3% (w/v) DPhPC in n-hexane. A conducting buffer 
(1 M KCl, 5 mM HEPES, pH 7.8) was added to both the top and bottom compartments of 
the BLM cell, and Ag/AgCl electrodes were placed in the buffer of each compartment. The 
electrode in the trans-compartment was connected to the headstage of an Axopatch 200B 
amplifier (Axon Instruments), and the electrode in the top compartment was grounded. A 
planar lipid bilayer was formed by painting the aperture with 0.5 µL of 3% (w/v) DPhPC 
in n-decane. 1 µL of the diluted Liposome/connector complex was added to the cis- 
compartment directly to fuse with the planar lipid bilayer to generate membrane embedded 
nanopores.  
Electrophysiological measurements 
The headstage and Axopatch 200B patch clamp amplifier were connected to a 
DigiData 1440 analog-digital converter (Axon Instruments, Inc.) to monitor and record 
electrochemical currents through BLMs(13,56,174). The current recordings were low-pass 
filtered at a frequency of 5 kHz. The sampling frequency was 200 kHz in all experiments, 
unless otherwise specified. The data were recorded a with pClamp 9.1 software (Axon 
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Instruments, Inc.), and analyzed with the Clampfit module of pClamp 9.1 and OriginPro 
8.1 (OriginLab Corporation).  
Peptide translocation experiments 
TAT peptide (Cys-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg) with a final 
concentration of 23 µg/mL was premixed with the conducting buffer before the insertion 
of connector.  For quantitative validation, Cy3 fluorophore was conjugated to TAT peptide 
by sulfhydryl-maleimide chemistry and purified by HPLC. Multiple channels were inserted 
into bilayer lipid membrane and then Cy3-TAT peptide was added into cis-chamber. 
Samples were collected from the trans-chamber after 0, 20, 40, and 60 min. The errors 
represent mean ± standard determined by Gaussian fit of the data. 
Single molecule fluorescence imaging: Samples collected from the patch clamp 
were incubated with the ozone pre-treated glass substrate for 10 min before imaging to 
ensure sufficient adsorption. A 532 nm green laser was used for the excitation of Cy3. A 
60× objective (N.A. = 1.4, oil immersion) was used for fluorescence imaging. The signals 
were recorded using Andor iXon 887 V electron multiplied CCD camera. Images were 
taken with an exposure time of 500 ms. The number of spots in the images were counted 
using iSMS software(216). The errors represent mean ± standard deviation from three 
independent imaging from one experiment. Three independent experiments were 
performed and similar trend was obtained as shown in Fig. 4.5.    
RESULTS AND DISCUSSION 
Characterization of SPP1 reengineered nanopore embedded in a lipid bilayer  
Structural analysis revealed that the central region of the SPP1 connector shows slight 
hydrophobicity compared with the flanking regions at the N- and C-terminal ends which 
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are more hydrophilic (Fig 4.1a-b). We reengineered the SPP1 connector by inserting a 
6×His-tag at the C-terminal end along with a 6×glycine linker for end-flexibility. The 
presence of His-tag enhanced the hydrophilicity of the C-terminal, thus making the 
hydrophilic‒hydrophobic‒hydrophilic layers of the connector more distinct, which is 
necessary to mimic the lipid bilayer architecture. After His-tag column purification, the 
purified protein was further purified by 15-35% glycerol gradient ultracentrifugation to 
verify whether SPP1 subunit could assemble into the channel complex (Suppl. Fig 4.1). 
Bovine serum albumin (BSA) with molecular weight of 60 KDa, which is almost equal to 
a single subunit (58 KDa) of the SPP1 connector, centered at fraction 27, whereas the SPP1 
portal complex was at fraction 17, indicating the formation of higher molecular weight 
complex. 
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Figure 4.1: Structure of the channel of SPP1 DNA packaging motor.  (a) Side view and 
(b) top view showing hydrophilic (red), hydrophobic (blue) and neutral (white) amino 
acids; and dimensions of the channel. PDB: 2JES. (c) Coomasie-blue stained SDS PAGE 
showing the purified SPP1 channel subunits gp6. 
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Supplemental Figure 4.1: Assembly of SPP1 gp6 subunits into 12 subunit connector 
complexes as shown by 15-35% glycerol gradient ultracentrifugation. BSA was used for 
size control. 
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To incorporate SPP1 portal channel into planar lipid membranes, a two-step 
procedure was employed(13). DPhPC lipids in chloroform were first dehydrated to remove 
organic solvents and then rehydrated with buffer containing 250 mM sucrose and purified 
connectors. The multilamellar lipid-connector suspension was then extruded through 400 
nm polycarbonate membrane filters to generate uniform unilamellar liposomes with the 
connector embedded in the membrane. The resulting liposome-connector complex was 
fused with a planar lipid membrane to generate planar membrane-embedded SPP1 
nanopore. Since the connector is neither a membrane protein nor an ion channel, direct 
incubation of the connector with a planar lipid bilayer did not result in connector insertion 
into the lipid bilayer. Single channel conductance assay was performed to measure the 
electrophysiological properties of membrane-embedded SPP1 connectors. The connector 
insertion steps were observed as distinct stepwise increase in conductance as revealed in a 
continuous current trace (Fig 4.2a). The insertion of single portal channel results in ~200 
pA in current jump under an applied potential of 50 mV in conducting buffer (1 M KCl, 5 
mM HEPES, pH 8). Occasionally ~400 pA current jumps were observed, attributed to 
simultaneous insertion of two connectors. The average conductance of reengineered SPP1 
connectors is 4.27±0.27nS (Fig 4.2b). The conductance is uniform without displaying any 
voltage gating phenomena under the reported conditions of ±50 mV (Fig 4.2c). At voltages 
greater than ±100 mV, SPP1 connector displayed discrete stepwise gating of the channel 
(217). 
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Figure 4.2: Electrophysiological properties of membrane-embedded SPP1 connector. 
(a) Current trace showing the insertion of SPP1 connector into the planar membrane with 
a characteristic step size of ~200 pA at ‒50 mV. (b) Conductance distribution based on 104 
insertion events. (c) Current-Voltage trace acquired from ‒50 → +50 mV. Buffer: 1 M 
KCl, 5 mM HEPES, pH 8. 
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Characterization of peptide translocation through reengineered SPP1 connector  
A positively charged 12 amino acid TAT peptide was used in the translocation 
studies with sequence Cys-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg. Due to the 
presence of cysteine at the N-terminus, the peptide forms a dimer by disulfide bond under 
physiological conditions, which is confirmed by mass spectroscopy. In the absence of 
peptide, the current trace was quiescent. In contrast, when the peptide was premixed with 
the conducting buffer in both cis- and trans-chambers, a burst of transient blockage events 
were observed immediately after the insertion of connector in the lipid membrane (Fig 
4.3a). As the peptide concentration was increased from 1.25, 2.5, 3.75, to 5 µg/mL, the 
density of current blockage events increased with a corresponding linear increase in peptide 
translocation rate from 2.33±1.54, 7.5 ±1.66, 10.17±3.58, to 16.96±6.01 events per second 
(Fig. 3b). One parameter used to characterize the translocation was the current blockage 
percentage, calculated as the ratio of current blockade resulting from peptide translocation 
to the open current of one portal channel, expressed as [ 1 ‒ (Currentpeptide / 
Currentopen_channel) ]. The distribution of current blockage was relatively broad with a major 
peak centered around 55.1±3.0%, determined by Gaussian fit of the data (Fig 4.3c). 
Another parameter was the dwell time (t), the time taken for the peptide to traverse from 
one end of the connector to the other end. The dwell time distribution followed an 
exponential decay with a rate constant of 0.84±0.09 ms-1 (Fig 4.3d).  
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Figure 4.3: Peptide translocation through SPP1 connector. (a) Current trace showing a 
burst of current blockage events with characteristic current amplitude and dwell time 
indicating the translocation of TAT peptides. A representative event is shown in insert. 
TAT peptide concentration: 0.5 µg/mL (b) Rate of peptide translocation as a function of 
peptide concentration (n = 3). (c) Histogram of current blockage percentage from 1978 
events. (d) Dwell time of peptide translocation events fitted with a single exponential 
function. Applied voltage: 50 mV; Buffer: 1 M KCl, 5 mM HEPES, pH 8. 
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Quantitative validation of peptide translocation by single molecule fluorescence imaging 
To validate the translocation of peptide through SPP1 connector, we conducted 
single molecule fluorescence imaging of samples collected from patch clamp experiments. 
HPLC purified Cy3 conjugated TAT peptide at a final concentration of 2.5 ng/µL was 
added to the cis-chamber after stable insertion of SPP1 connectors in the lipid bilayer. 
Under an applied negative trans-membrane voltage, the positively charged peptide 
translocated through the portal channel to the trans-chamber. 50 µL samples were collected 
from the trans-chamber at 0, 20, 40, and 60 minutes after addition of Cy3-TAT peptide 
and loaded onto glass coverslips. The positively charged peptide can bind to the negatively 
charged glass surface through charge-charge interactions and appear as individual 
fluorescent spots (Fig 4.4a). Fluorescence imaging revealed that the number of Cy3 spots 
in the field of view increased over the time course of 60 mins (Fig 4.4b). In contrast, in a 
control experiment under the same conditions but in the absence of portal channel, very 
few Cy3 spots were observed, compared to the sample containing SPP1 connector (Fig 
4.4b). Since TAT is a membrane penetrating peptide, it is conceivable that a small fraction 
could potentially pass through the lipid bilayer, contributing to the small increase in the 
fluorescence background signal.  
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Figure 4.4: Single molecule fluorescent images validating TAT peptide translocation. 
(a) The upper row is the image showing the detection of Cy3-labeled TAT peptide from 
the fractions collected from patch clamp at 0, 20, 40 and 60 mins. Excitation l: 532 nm; 
laser power: 5 mW; 60× objective (N.A. = 1.4, oil immersion); Exposure time: 500 ms. (b) 
Quantitative analysis showing the increase in Cy3-TAT peptide signal in presence of SPP1 
connector compared to control without connector. The errors represent mean ± standard 
deviation from three independent imaging from one experiment. Three independent 
experiments were performed and similar trend was observed. Applied voltage: 50 mV; 
Buffer: 1 M KCl, 5 mM HEPES, pH 8.  
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Kinetic analysis of TAT conformational status in real time 
The focus of this study was to investigate whether the SPP1 motor channel can be 
used for kinetic analysis of peptides in real time. TAT peptide with and without a cysteine 
was used as a model system to study oligomeric states. Structural analysis of TAT sequence 
using the computer program PEP-FOLD (218) revealed that without forming disulfide 
bond, the TAT only adopts one α-helical conformation (Fig 4.5). However, in the presence 
of a cysteine at the N-terminus, the peptide can be oxidized into a dimer by forming a 
disulfide bond between two N-terminal cysteines and exhibiting two parallel α-helices or 
extended linear conformation. The presence of two states, the oxidized and the reduced 
conformations, were confirmed by translocation studies with the SPP1 portal channel. 
Under an oxidized state, the current blockage distribution by TAT displayed a major peak, 
centered at 55.1±3.0% (Fig 4.5a), with a minor peak centered at 28.5±1.9%. However, 
after adding the reducing agent TCEP [(tris(2-carboxyethyl)phosphine)] to break the 
disulfide bond, the blockage distribution significantly changed. The peak of 55.1±3.0% 
decreased significantly over time, while the majority of the blockage distribution shifted to 
28.5±1.9%. This indicated that most of the peptide passing through the channel is in its 
single α-helical conformation (Fig 4.5b). Current blockage distribution of the reduced TAT 
peptide was similar to Cy3-TAT signature with TCEP treatment, since the conjugation of 
Cy3 prevented the disulfide bond formation and resulted in similar blockage, representing 
the single TAT helix (Fig 4.5c).  
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Figure 4.5: Determining the conformational states of TAT peptide. Current trace (left), 
current blockage distribution (middle) and conformation (right) for (a) oxidized dimer state 
of TAT peptide; (b) reduced monomer state of TAT peptide; and (c) Cy3-conjugated TAT 
monomer. Applied voltage: 50 mV; Buffer: 1 M KCl, 5 mM HEPES, pH 8. Total number 
of events: 858 in A; 367 in B and 1128 in C.  
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To quantify the kinetics parameter, we further examined the conformational 
changes of TAT peptide upon addition of TCEP and recorded the change of the current 
blockage profile in real time (Fig 4.6). It was found that current blockade signature 
progressively shifted from predominantly 55.1±3% (oxidized dimer) to 28.5±1.9% 
(reduced monomer), representing the real-time kinetic process of disulfide bond reduction 
(500 µM TCEP, Fig 4.6A). The TCEP reduction process can be described as a pseudo-first 
order reaction due to the nearly infinite TCEP amount and the reaction equation is 
described as follows: 
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C0 and εC0 are TAT dimer and monomer concentration prior to adding TCEP; Ct is 
TAT dimer concentration at any giving reaction time t; k is the rate constant. C(t) represents 
the TCEP concentration at the pore entrance. Due to the limited capture radius of 
nanopores, only chemicals at the pore entrance can be effectively captured and detected 
(219,220). After adding TCEP into cis-chamber, the reductant gradually diffused to the 
pore entrance and reduced TAT dimer to monomer.  
 
According to three dimensional diffusion equation, C(t) has the following equation: 
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, where D is the diffusion constant of TCEP and r is the 
distance from the pore entrance to TCEP injection location. To simplify the representation 
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of this reaction kinetics, two parameters γ (defined as the ratio of the number of dimer 
events versus the sum of dimer and monomer events, 
][][
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ºg ) and 
reaction quotient Qr (
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Solving the above equations yields: 
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Here, CT is the final TCEP concentration at diffusion equilibrium state. 
Experimentally, γ and Qr can be derived from the concentration of TAT dimer and 
monomer, which is represented by the number of the dimer (with 40% ~ 70% blockade, 
5σ) and monomer (with 19% ~ 38% blockade, 5σ) translocation events(220). By 
calculating those two parameters at each reaction time, the transition of γ and Qr as shown 
in Fig. 4.6B and Fig. 4.6D represents the temporal evolution of the reduction reaction. The 
red line in Fig. 4.6B is the fitting curve with equation (2) (500 µM TCEP as that in Fig 
4.6A). γ decreased over the course of reaction time, indicating a decrease in oxidized dimer 
conformation and concurrent increase in reduced monomeric state. Fitting the data revealed 
a rate constant k = 0.989 ± 0.096 min-1. The trend is also demonstrated in current blockage 
percentage vs. dwell time distribution of events over the course of the reaction time (Fig 
4.6C). Qr (500 µM TCEP) in Fig. 4.6D, derived from γ with equation (3), reached a plateau 
when the reaction approached equilibrium. The plateau Qr is equal to standard equilibrium 
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constant Kᶱ, estimated to be 1.4×104 and corresponding to ‒23.3 kJ/mol Gibbs free energy 
(ΔGᶱ = -RTlnK). All the reduction data from different concentration of TCEP show the 
same trend to approach equilibrium status (Fig 4.6D). When the concentration of TCEP 
was increased from 100, 250, to 500 µM, the ΔGᶱ were ‒24.5, ‒23.1, and ‒23.3 kJ/mol 
(Table 4.1), respectively. The ΔGᶱ derived from our assay is very close to the ΔGᶱ of ‒27 
kJ/mol for protein disulfide bond reduction by TCEP obtained by conventional Raman and 
computational methods (221). 
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Figure 4.6: Real-time assessment of the conformational states of TAT peptide. (a) 
Continuous current trace showing transition of oxidized dimer states to reduce monomer 
states after addition of reducing agent TCEP. (b) Quantitative analysis showing the fraction 
(g) of dimer and monomer states as a function of reaction time. (c) Current blockage versus 
dwell time distribution over the course of reaction time. Applied voltage: 50 mV; Buffer: 
1 M KCl, 5 mM HEPES, pH 8. (d) Quantitative analysis showing the reaction quotient Qr 
as a function of reaction time. 
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Table 4.1: Parameters for the quantification of the oligomeric states of TAT peptide in 
real time 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[TAT] (nM) [TCEP] 
(µM) 
Qr (103) K0(103) ΔG0 (kJ/mol) 
300 100 26.6 26.6 -24.5 
300 250 11.8 11.8 -23.1 
300 500 13.9 13.9 -23.1 
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Discussion 
In this study, we showed that the SPP1 portal channel can be successfully 
incorporated into planar lipid bilayer to serve as a nanopore with robust 
electrophysiological properties. With a conductance of 4.27 nS, it is one of the larger 
channels and only the second viral protein channel (apart from phi29 connector)(13) to be 
incorporated into a lipid membrane. In the presence of TAT peptide, a burst of current 
blockage events with characteristic current amplitude and dwell time were observed 
indicating the translocation of the peptides through the SPP1 connector. In this study, we 
further demonstrated that this new protein nanopore is capable of detecting kinetics of 
TCEP mediated reduction of disulfide bond and demonstrating peptide conformational 
changes in real time. From Fig. 4.6, the frequency of dimer forms (current blockage of 
~55%) decreased gradually to monomer forms (current blockage of 30%), upon addition 
of TCEP, as the reaction time increased. The oligomerization states of peptides was 
determined in real-time at single molecule level, which is not possible by ensemble 
techniques like NMR, Circular Dichroism, and optical second harmonic generation. 
Direct evidence of DNA translocation through α-hemolysin was demonstrated 
twenty years ago by quantitative PCR(222). Although several studies utilizing peptide and 
protein translocation through nanopores, have been published over the last several years 
(204-206,210-214), direct method for validating peptide translocations are lacking. A 
recent publication tried to solve the problem by conjugating a single-stranded DNA to 
unfolded protein and then amplify the DNA using PCR after translocation(223). Another 
study demonstrated the translocation of hyaluronic acid oligosaccharides using high-
resolution mass spectrometry(224). Here, we developed a very simple method to provide 
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evidence of peptide translocation using single molecule fluorescence imaging of samples 
obtained from the nanopore setup. This method can be easily adapted and employed by 
other laboratories to validate protein translocation and quantitatively study peptide 
dynamics through nanopores.  
The current blockage signature based on the translocation profile can potentially be 
used to investigate the length, charge, hydrophobicity, secondary structures and ultimately 
the amino acid sequences of the peptides. The kinetics of protein folding and unfolding as 
well as entropic and energetic contributions can be further dissected in the future at the 
single molecule level.  
CONCLUSIONS 
The portal channel of bacteriophage SPP1 has been reengineered and inserted into 
lipid bilayer to allow the translocation of peptides with higher ordered structure to produce 
clear and reproducible electronic signatures. The translocation of peptides observed by 
single channel conduction assays were verified by optical single molecule fluorescence 
microscopy assays. The oxidative and the reduced conformation of peptides were clearly 
differentiated in real-time at single molecule level. When different concentrations of 
substrates were applied, a similar ΔG0 was obtained, suggesting that the use of SPP1 
nanopore for real-time dynamic quantification of peptide folding is feasible.  
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Chapter 5: Realizing Short Peptide Detection by Enforcing Peptide-
Pore Electrostatic Interaction using SPP1 DNA Packaging Motor  
This chapter is under preparation for submission. Special thanks to Zhengyi Zhao for help 
and assistance in preparation of data for figures 5.1 and Dr. Zhi Zhou for help in preparation 
of data for figure 5.2, 5.3, and 5.4.  
INTRODUCTION 
Nanopore technology has recently emerged as a high-throughput and cost-effective 
single molecule detection method, holding great potential for sensing and biopolymer 
sequencing(3,4,69). However, one of the critical challenges is the ultra-fast translocation 
of these biopolymer through nanopore which is far beyond electronic detection limits. To 
realize DNA sequencing, the first step is to slow down translocation speed. To solve this 
problem, many attempts have been made, such as controlling the electrolyte temperature, 
viscosity, the electrical bias voltage, conducting buffer and introducing DNA 
polymerase(64,66-68). Due to its unique property, currently DNA polymerase has been 
widely used in DNA sequencing(68,69). 
Study the folding of protein and sequencing protein is significant for predicting 
protein structure and revealing its biological function in many physiology processes. As a 
counterpart polymer, using nanpore for probing protein structure, folding, detection and 
sequencing is in early stage because it is still lack of an effective and simple method to 
slow down the ultra-fast translocation speed. Digesting protein molecule into amino acids 
and discriminating them with nanopore sequentially may be a possible way toward protein 
sequencing. One of main obstacles is that short amino acids pass through the protein pore 
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too fast to be detected with the nowadays available electronics. To slowing down peptide 
translocation, numerous attempts were made, such adjusting pH (198) and using the AAA+ 
unfoldase ClpX (225). 
SPP1 is a dsDNA bacteriophage that infects Bacillus subtilis. The central of DNA 
packaging motor of the SPP1  is a portal channel, termed connector, which is composed of 
12 or 13 copies of protein gp6 (57,186). The connector has an overall diameter of 16 nm 
and a height of 10.5 nm. The narrowest constriction of the internal channel is ~3 nm (Fig. 
5.1)(57,58) which is large compared with other commonly used protein channel, such as 
α-Hemolysin, MspA, with an internal channel diameter of less than 2 nm(40,73,192). 
Compare to other larger protein pores such as ClyA(193) and FhuA(194), the uniqueness 
of the SPP1 channel is it’s highly negative charge inside the channel. This provide this 
channel unique advantage to slow down positive charged peptide translocation.  
In this work, the peptides translocation was slowed down in SPP1 DNA packaging 
motor with low NaCl concentration buffer. The underlying mechanism is that reduced 
charge screening effect resulted from low salt concentration enhanced electrostatic 
attractive force between the peptide and pore, which therefore slow down peptide 
translocation speed. A factor of 500-fold reduction was observed for TAT peptide 
translocation. Appling such condition in detecting arginine chain peptide allow us to 
measure peptide as short as two arginine amino acids. Further improve the bandwidth may 
lead to single amino acid detection and protein sequencing. 
MATERIALS AND METHODS 
Materials 
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The phospholipid 1, 2-diphytanoyl-sn-glycerol-3-phosphocholine (DPhPC) was 
obtained from Avanti Polar Lipids, Inc. Organic solvents (n-decane and chloroform) were 
purchased from Fisher Scientific, Inc. and TEDIA, Inc., respectively. TAT peptide and 
various lengths of poly arginine were custom-ordered from GenScript, Inc. All other 
reagents were purchased from Sigma or Fisher, if not specified.  
Cloning and Purification of the SPP1 connector channel 
Gene gp6 encoding SPP1 channel was synthesized and cloned into PET3 vector 
between NhdeI and BamHI by GenScript, Inc. His-tag was inserted into the C-terminal of 
the SPP1 channel for purification. The plasmid was transformed into BL21 (DE3) for 
expression and purification. The purification procedure has been described in previous 
publications(13,174). Briefly, the transformed bacteria were cultured overnight at 37°C in 
10 mL LB medium. Then the bacteria were transferred to 1 L of LB medium and cultured 
until OD600 reaching ~0.5-0.6. Then 5 mM IPTG was added to the medium to induce 
protein expression. After 3 hours continuous culture, the bacteria were collected by 
centrifugation. Bacteria was lysed by passing through French press. Lysed cell was 
separated by centrifugation, and supernatant containing expressed protein was collected 
and purified with Nickel affinity chromatography (Novagen) (133). His Binding Buffer 
(15% glycerol, 0.5 M NaCl, 5 mM Imidazole, 10 mM ATP, 50 mM Tris-HCl, pH 8.0), and 
the cleared lysate was loaded onto a His•Bind® Resin Column and washed with His 
Washing Buffer (15% glycerol, 0.5 M NaCl, 50 mM Imidazole, 50 mM Tris-HCl, pH 8.0). 
The His-tagged SPP1 channel was eluted by His Elution Buffer (15% glycerol, 0.5 M NaCl, 
0.5 M Imidazole, 50 mM Tris-HCl, pH 8.0). The purified SPP1 channel from 
chromatography was further purified by a 15-35% glycerol gradient ultracentrifugation at 
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35K for 2 hrs. Before incorporating into liposomes, the purified SPP1 channel was dialyzed 
against buffer (0.5 M NaCl, 50 mM Tris-HCl, pH 8.0) to remove excess glycerol. 
Insertion of the connector into planar lipid bilayer: The protocol for incorporation 
of connector channel into lipid bilayer has been published previously (13,56,110,131,174). 
Briefly, the dehydrated lipid film was formed after the chloroform in 150 µL of 10 mg/mL 
DPhPC lipids was evaporated in a round bottomed flask, and then rehydrated with 300 µL 
buffer containing 250 mM sucrose and purified connectors (0.5-1 mg/mL). The suspension 
was thoroughly vortexed and kept at 45 °C (above the phase transition temperature of 
DPhPC) followed by extrusion through 400 nm polycarbonate membranes (Avanti Polar 
Lipids) to produce uniform sized liposome/connector complexes.  
Planar bilayer lipid membranes (BLMs) were produced in a BCH-1A horizontal 
BLM cell (Eastern Scientific). A Teflon partition with a 200 µm aperture was used in the 
apparatus to separate the BLM cell into two compartments. The aperture was pre-painted 
with 0.5 µL of 3% (w/v) DPhPC in n-hexane. A conducting buffer was added to both the 
top and bottom compartments of the BLM cell, and Ag/AgCl electrodes were placed in 
each compartment. The electrode in the trans-compartment was connected to the headstage 
of an Axopatch 200B amplifier (Axon Instruments), and the electrode in the top 
compartment was grounded. A planar lipid bilayer was generated by painting the aperture 
with 0.5 µL of 3% (w/v) DPhPC in n-decane. 1 µL of the diluted Liposome/connector 
complex was added to the top compartment directly to generate membrane embedded 
nanopores.  
Electrophysiological measurements: The Axopatch 200B patch clamp amplifier 
and headstage were connected to a DigiData 1440 analog-digital converter (Axon 
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Instruments, Inc.) to monitor and record electrochemical currents(13,56,174). The current 
recordings were low-pass filtered at a frequency of 5 kHz. The sampling frequency was 
200 kHz in all experiments, unless otherwise specified. The data were recorded with 
pClamp 9.1 software (Axon Instruments, Inc.), and analyzed with the Clampfit module of 
pClamp 9.1 and OriginPro 8.1 (OriginLab Corporation).  
Peptide translocation experiments 
TAT peptide (Cys-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg) with a final 
concentration of 23 µg/mL was premixed with the conducting buffer before the insertion 
of connector channel. For R2, R4, R6, R8, and R10 translocation study, a final 
concentration of 23 µg/mL was premixed with conducting buffer before the insertion of 
connector channel. 
RESULTS  
Charge distribution of SPP1 and α-Hemolysin 
Fig. 5.1 shows the charge (blue: positive; red: negative) distribution of α-
Hemolysin and SPP1 protein nanopore from outside and inter-section view. In α-
Hemolysin, both outside and inside of the channel lumen is mainly composed of positive 
charged amino acids. By contrary, negative charged amino acid residues are clustered 
outside and the lumen of SPP1 channel, resulting in highly negative charge density. This 
property of SPP1 has blocked DNA or RNA translocation through the channel even under 
high voltage in 1 M KCl buffer due to electrostatic repulsing force (data not shown). By 
screening such force in 2 M LiCl buffer, DNA translocation events has been be observed 
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due to the higher shielding effect of LiCl than KCl (data not shown). This unique property 
of SPP1 provides this channel better capability to detect short positive charged molecule. 
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Figure 5.1 Charge distribution of α-Hemolysin and SPP1 protein nanopore from outside 
and inter-section view ((blue: positive; red: negative)).  
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Slowing down TAT translocation by reducing slat concentration  
To study the effect of electrostatic attractive force on peptide translocation velocity 
through SPP1, a series NaCl concentrations were used to detect the positive charged TAT 
peptide (sequence: CYGRKKRRQRRR), of which translocation was studied previously 
(94). Fig.5.2 presents typical current trace and TAT translocation events (Left) under 2 M, 
1 M, 0.4 M, and 0.2 M NaCl buffer with the same applied voltage and pH. The translocation 
events under lower NaCl concentration has displayed much longer dwell time than those 
under higher NaCl concentration, whereas the blockade of TAT peptide under these salt 
concentration are the same majoring in 55%. Supplementary Fig.5.1 has shown the dwell 
time distribution of TAT under these salt concentration. To quantitatively analyze the salt 
effect on slowing down peptide translocation speed, TAT dwell times under each 
concentration were derived and plotted in Fig.5.2. From the plot, it has clearly shown that 
dwell time tends to increase when reducing NaCl concentration. The dwell time under 1, 
2, 1.5, 0.8, 0.6, 0.4, 0.3,0.2 M NaCl are 1.37±0.07, 0.18±0.01,1±0.09, 4.16±0.12, 
8.96±0.38, 12.45±0.08, 63.46±1.05, and 54.30±1.30 ms.  
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Figure 5.2 Salt concentration effect on peptide translocation. Representative current 
trace of TAT translocation through SPP1 nanopore under 2 M, 1 M, 0.4 M, and 0.2 M NaCl 
buffer (Left). and TAT translocation events (Left). TAT dwell times versus concentrations 
(Right).  
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Supplementary   Figure   5.1   Dwell   time   distribution   of   TAT   under   different   NaCl  
concentration  with  same  pH  and  50  mV  applied  voltage.  
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Detect short arginine chain peptide  
Based on the capability of slowing down peptide translocation speed, 0.3 M NaCl 
buffer (pH 7.9) was chosen to further test whether short poly arginine peptides (R2, R4, 
R6, R8, and R10), can be detected. Supplementary Fig.5.2 presents typical current trace 
of R2, R4, R6, R8, and R10 translocation through SPP1 nanopore. Fig.5.3 has shown the 
current blockade of R2, R4, R6, R8, and R10 and the blockades are 23.3±2.2, 35.8±2.6, 
29.7±4.3, 32.0±2.3, and 32.7±2.0 respectively. Supplementary Fig.5.3 has shown the 
dwell time distribution of R2, R4, R6, R8, and R10 and the dwell time are 0.080±0.002, 
0.100±0.001, 0.154±0.005, 0.337±0.009 and 0.531±0.009 respectively. The dwell time for 
each peptides was derived as previously described (94,220) and plotted in Fig. 5.4. To 
exclude the bandwidth effect, only the events with dwell time longer than 0.2 ms (5 kHz 
bandwidth) were selected to analyze blockade for each peptides.  
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Supplementary Figure 5.2 Representative current trace of f R2, R4, R6, R8, R10 under 
0.3M NaCl, 5mM Hepes, pH 8 with 50 mV applied voltage. 
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Figure 5.3 Blockade distribution of R2, R4, R6, R8, R10 under 0.3M NaCl, 5mM Hepes, 
pH 8 with 50 mV applied voltage. 
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Supplementary Fig.5.3 Dwell time distribution of R4, R6, R8, R10 under 0.3M NaCl, 
5mM Hepes, pH 8 with 50 mV applied voltage. 
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Figure 5.4 The dwell time versus various length of amino acids under 0.3M NaCl, 5mM 
Hepes, pH 8 with 50 mV applied voltage. 
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DISCUSSION 
For the first-order approximation, Debye length is proportional to 1/C^0.5, and 
electro-kinetic velocity is on the order of 1/C (226). The red curve in Fig. 5.2 is a simulation 
with function y = A/C, where A is a normalized constant and C is NaCl concentration. The 
fitting result shows similar trend with experimental data. The mismatch of the experiment 
data and the simulation may arise from several factors: (1) the ignorance of the charge 
screening of TAT peptide itself; (2) the electro-osmotic effect; (3) possible friction between 
TAT peptide and SPP1. The counter-trend data at 0.2 M is even smaller than that in 0.3 M 
NaCl buffer, which may arise from the increased electric driving force due to screened 
TAT peptide charge.  
Compared to R4, R6, R8, and R10, which has shown only one peak, R2 blockade 
displayed a double-peak distribution. It is speculated that the double peak may arise from 
two different manners (head-to-tail or shoulder-by-shoulder) of R2 translocation through 
SPP1, while for longer arginine chain, only head-to-tail manner is allowed. 
Recently, Long et al. reported that aerolysin can discriminate Adenine chain from 
2 to 10 nucleotides in length by blockade difference which were attributed to the 
electrostatic interactions between oligonucleotides and aerolysin, and the geometry which 
does not contain constrict site (39). In this study, 2, 4, 6, 8, 10 arginine amino acids can be 
differentiated based on dwell time rather than blockade, as shown in Fig. 4. This is because 
the short peptide shows short dwell time, even though the short peptide events may re-
shaped by the built-in filter. The blockade of R2 is about 23%, whereas the blockade of 
R4, R6, R8, and R10 have similar blockade distribution about 35%. This indicated the 
depth of the constrict site of SPP1 can probably only accommodate 4 amino acids length 
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peptide, and any peptide longer than 4 amino acids will not contribute to blockade. This 
demonstrates that SPP1 nanopore has a high longitudinal spatial-resolution and can 
potentially be applied for protein sequencing in the future.  
CONCLUSION 
In conclusion, TAT and arginine chain peptides were detected with SPP1 DNA 
packaging motor embedded in lipid bilayer. The dwell time of peptides can be tuned by 
modulating the electrostatic attractive force between peptide and SPP1 through slat 
concentration. In 0.3 M NaCl buffer (pH 7.9), TAT demonstrated the highest dwell and 
lowest translocation velocity. Appling such condition to short arginine chain peptide allow 
us to sense arginine chain as short as just two arginine amino acids, which is the state-of-
art result. 
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Chapter 6: Biomimetic RNA-based Nanopore for Short Peptide 
Detection 
This chapter is under preparation for submission. Special thanks to Hui Li for help and 
assistance in preparation of data for figures 6.1, 6.2, 6.3, and 6.4.  
INTRODUCTION: 
Nanopore technology has emerged as a cost-effective and high-throughput single 
molecule detection method, holding great potential for sensing and biopolymer sequencing 
over the last two decades(3,4,69). To date, many biological nanopore such as α-hemolysin 
(7), MspA (8), and viral connectors have been successfully used for incredibly versatile 
applications including detection of small molecules, macromolecule, polymers, 
polypeptides, as well as DNA and RNA (15-17). All of these nanopore come from 
biological system with defined channel size and physical property. Creating a new pore de 
novo with the ability to accurately tune the size and its functionality is still of great interest 
in fundamental and applied science. One of the key challenges in the de novo design of 
membrane channel is, to achieve a defined architecture in atomic scale with defined size, 
shape and properties (227). 
Inspired by biological channels, synthetic nanopore constructed entirely by DNA 
has been reported previously and serve as cytotoxic agents(228) and drug carriers (229) .  
One of the designs was constructed with scaffolded DNA origami which was composed of 
a stem and a barrel-shaped cap (230). Another type was generated based on the archetypal 
six-helix-bundle structure that enclose a 2-nm-wide lumen with a tunable height (227). In 
order to insert negatively charged pore into the hydrophobic bilayer membrane, 
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hydrophobic anchors, such as cholesterol(230), porphyrin(228), and ethane-PPT groups 
(231) were included in all these artificial pore.  
Over the last decade, RNA nanotechnology has advanced rapidly and attracted 
widespread attention due to the potential for applications in material and medical sciences 
(232-234). Naturally occurring RNA molecules can fold into unique 3D structures and 
perform various biological functions in vitro and in vivo. Compared to DNA, RNA has 
higher diversity in structure and function.  Due to their diversity in structures and functions, 
RNA molecules were used as building blocks for engineering various de novo architectures 
with unique physical/biochemical properties via bottom-up self-assembly. Varieties of 
RNA architectures with defined shape, size and stoichiometry have been created for diverse 
applications, such as therapeutics delivery, cancer targeting, immunomodulation, and 
sensing(232,233,235).  
By introducing polymerase or exonuclease, significant progress has been made in 
DNA sequencing using nanopore (68,69,72).  However, so far there is still lack of effective 
way for protein sequencing which is critical for understanding its biological function in 
many physiology processes. One of possible method toward protein sequencing is to digest 
protein molecule into amino acids and discriminate them using nanopore sequentially. One 
of main obstacles is that short amino acids pass through the protein pore too fast and are 
hard to be detected with the nowadays available electronics. 
To expand biological nanopores and explore new features of artificial nanopores, 
here we constructed and assembled RNA nanopores with two different designs. The 
insertion of RNA nanopore into lipid bilayer and cell membrane were further characterized. 
Translocation of short amino acids through RNA nanopore was detected and characterized. 
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Translocation of short amino acids is first time observed in artificial nanopore. This new 
artificial nanopore has the potential to be used for sensing, disease diagnosis and even 
protein sequencing.  
MATERIALS AND METHODS: 
Materials 
 The phospholipid 1, 2-diphytanoyl-sn-glycerol-3-phosphocholine (DPhPC) was 
obtained from Avanti Polar Lipids, Inc. Organic solvents (n-decane and chloroform) were 
purchased from Fisher Scientific, Inc. and TEDIA, Inc., respectively. Poly arginine with 2, 
4, 6, 8, 10 amino acids peptide was custom-ordered from GenScript, Inc. n-octyl-oligo-
oxyethylene was purchased from Enzo company.  All other reagents were purchased from 
Sigma or Fisher, if not specified.  
Design, synthesis, and self-assembly of RNA nanopores 
The NanoEngineer program was used to facilitate the design of the RNA tubes. 
Unmodified RNA strands were synthesized by in vitro T7 transcription and purified by 8 
M urea, 8% denaturing PAGE. DNA templates for transcribing the RNA strands were made 
by polymerase chain reactions (PCR). DNA oligonucleotides for PCR were directly 
ordered from IDT, Inc. Cholesterol modified RNA strands were ordered from IDT or 
synthesized by Azco Oligo-800 DNA and RNA synthesizer. 
 The RNA tubes were self-assembled in a one-pot manner by mixing the synthesized 
RNA strands in equimolar concentrations in 1×TMS buffer and heated to 95 °C and slowly 
cool down to room temperature. The step-wise self-assembly of the RNA tubes was 
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examined by agarose gels.  The gels were stained with Ethidium Bromide (EB) and imaged 
by Typhoon FLA 7000 (GE Healthcare). 
Atomic force microscopy 
 The RNA tubes were imaged by atomic force microscopy (AFM), following 
previously described methods. Briefly, RNA tubes were placed on the APS-modified mica 
surface and excess samples were washed with DEPC water and dried before imaging. AFM 
imaging was performed by using the MultiMode AFM NanoScope IV system (Veeco) 
operated in tapping mode.  
In vitro binding of RNA nanopores to cancer cells 
Prostate cancer LnCap cells were grown on glass cover slides in 24-well plates in 
RPMI-1640 medium with 10% FBS at 37°C in humidified air containing 5% CO2 
overnight. RNA nanopores harboring chosterol and labeled by Cy5 were diluted in optium-
MEM medium to 100 nM and incubated with the cells for  2 hrs at 37 °C. RNA nanopores 
without cholesterol and single strand RNA were used as the negative control. After the 
incubation, the cells were washed with PBS and fixed by 4% paraformaldehyde. Alexa488 
Phalloidin (Life Technologies) was used to stain the cellular actin.  The Prolong Gold 
antifade reagent with DAPI (Life Technologies) were then used to stain the cell nucleuses 
and mount the cells to the glass slides. The confocal images were recorded by the FluoView 
FV1000-Filter Confocal Microscope System (Olympus). 
Insertion of the RNA nanopore into planar lipid bilayer 
Briefly, planar bilayer lipid membranes (BLMs) were generated in a BCH-1A 
horizontal BLM cell (Eastern Scientific). A Teflon partition with a 200 µm aperture was 
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placed in the apparatus to separate the BLM cell into cis- (top) and trans- (bottom) 
compartments. A planar lipid bilayer was formed by painting the aperture with 0.5 µL of 
3% (w/v) DPhPC in n-decane. A conducting buffer (1 M KCl, 5 mM HEPES, pH 7.8) was 
added to both the top and bottom compartments of the BLM cell, and Ag/AgCl electrodes 
were placed in the buffer of each compartment. The electrode in the trans-compartment 
was connected to the headstage of an Axopatch 200B amplifier (Axon Instruments, Inc.), 
and the electrode in the top compartment was grounded. 
For direct insertion, a mixture of cholesterol-anchored RNA nanopores and 0.5% 
n-octyl-oligo-oxyethylene dissolved in conducting buffer was added to the cis side of the 
bilayer to a final concentration of 100 nM nanopores. For pore insertion with liposome, a 
two-step procedure was employed(13) for this design. DPhPC lipids in chloroform were 
dehydrated to eliminate solvents first and then rehydrated with buffer containing 250 mM 
sucrose and purified RNA nanopore with a final concentration 250 nM. The multilamellar 
lipid-RNA nanopore suspension was then extruded through 400 nm polycarbonate 
membrane filters to generate uniform unilamellar liposomes with the RNA naopore 
embedded in the membrane. The resulting liposome-RNA nanopore complex was fused 
with a planar lipid membrane to generate planar membrane-embedded RNA nanopore. 
Electrophysiological measurements 
The headstage and Axopatch 200B patch clamp amplifier were connected to a 
DigiData 1440 analog-digital converter (Axon Instruments, Inc.) to monitor and record 
electrochemical currents through BLMs(13,56,174). The current recordings were low-pass 
filtered at a frequency of 5 kHz. The sampling frequency was 20 kHz in all experiments, 
unless otherwise specified. The data were recorded a with pClamp 9.1 software (Axon 
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Instruments, Inc.). The blockades were calculated with a home-built Matlab program and 
statistically analyzed with OriginPro 8.1 (OriginLab Corporation). The capture rate was 
derived by exponentially fitting the time interval between two adjacent events as described 
previously (236). For peptide translocation experiments, poly arginine was premixed with 
conducting buffer with a final concentration of 1 µg/mL before the insertion of RNA 
nanopore.  
RESULTS AND DISCUSSION: 
Design, synthesis, and self-assembly of RNA nanopores  
RNA tubes were designed by using NanoEngineer software. In the first RNA 
nanopore design, six RNA strands were used to assemble the tube by utilizing a RNA 
origami approach similar to DNA origami (Fig 6.1). Six RNA strands were designed to 
fold together to form a hollow channel with the insider diameter of 1.7nm and the outsider 
diameter of 6.3nm. To assemble the RNA nanopore with cholesterol, two more chemically 
synthesized RNA strands with cholesterol at the end were added to the structure. For 
assembling, the synthesized RNA strands were mixed in stoichiometric ratio and annealed 
in 1×TMS buffer in a one-pot manner. Step-wise self-assembly of the RNA nanopores with 
and without cholesterol was examined by agarose gels, confirming the formation of the 
high molecular weight RNA nanopores (Fig.6.2).  
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Figure 6.1 Design and schematic view of origami designed RNA nanopore. (a) Map of 
the RNA nanopore composed of 6 RNA strands labeled by six different color. The two 
yellow squares indicate two cholesterol molecules. (b) Schematic top view (left) and side 
view (right) of RNA nanopore structure.  
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Figure 6.2 Assemble and AFM of origami designed RNA nanopore. (a) 4% Agarose 
gel electrophoresis. Lane 1: Strand 1. Lane 2: Srands 1+2. Lane 3: Srands 1+2+3. Lane 4: 
Srands 1+2+3+4. Lane 5: Srands 1+2+3+4+5. Lane 6: Srands 1+2+3+4+5+6. Lane 7: DNA 
Ladder. (b) 4% Agarose gel electrophoresis. Lane 1: Strand 1. Lane 2: Srands 1+2. Lane 
3: Srands 1+2+3. Lane 4: Srands 1+2+3+4. Lane 5: Srands 1+2+3+4+5. Lane 6: Srands 
1+2+3+4+6. Lane 7: Srands 1+2+3+4+6+3’Chol-RNA. Lane 7: Srands 
1+2+3+4+6+3’Chol-RNA+5’ Chol-RNA.Lane 9: DNA Ladder. (c) AFM analysis of RNA 
nanopore: representative individual RNA nanopore (left) and whole view of RNA 
nanopore (right)  
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For the second RNA nanopore design with three cholesterol molecules, six RNA 
strands were designed to be bound together by base paring and each RNA strand form one 
face of the six-helix channel. Similar channel size with the first RNA nanopore design was 
predicted, since both designs were composed of six RNA helixes bound together (Fig 
6.3A).  Compared with previous design, this approach has several advantages, such as ease 
of fabrication, higher yield of pores at higher concentration, and lower synthesis cost. 
Fig.6.3B has shown RNA nanopore without cholesterol can successfully assemble high 
molecular weight RNA nanopores step-wisely. However, after incorporate the three strands 
with cholesterol molecules, the assembled structure cannot run into gel and stuck in the 
loading well. This is possibly due to the formation of aggregated structure resulted from 
the hydrophobic interaction between cholesterol molecules (Fig 6.4C).  
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Figure 6.3 Design and assemble of six bundled RNA nanopore. (a) Map of the RNA 
nanopore six RNA strands which bound together by base paring and each RNA strand form 
one face of the six-helix channel. (b) 4% Agarose gel electrophoresis to confirm assemble 
of six bundled RNA nanopore. Lane 1: Strand 1. Lane 2: Srands 1+2. Lane 3: Srands 
1+2+3. Lane 4: Srands 1+2+3+4. Lane 5: Srands 1+2+3+4+5. Lane 6: Srands 
1+2+3+4+5+6. Lane 7: DNA Ladder. (b) 4% Agarose gel electrophoresis to confirm 
assemble of six bundled RNA nanopore with three cholesterol. Lane 1: Strand 1with 
cholesterol (chol). Lane 2: Srands 1(Chol)+2. Lane 3: Srands 1(chol)+2+3(chol). Lane 4: 
Srands 1(chol)+2+3(chol)+4. Lane 5: Srands 1(chol)+2+3(chol)+4+5(chol). Lane 6: 
Srands 1(chol)+2+3(chol)+4+5(chol)+6. Lane 7: DNA Ladder. 
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Atomic force microscope characterization of RNA nanopores  
Atomic force microscope was used to characterize the RNA nanopores. As shown in the 
AFM images, individual RNA nanopore can be clearly observed under AFM (Fig.6.2C, D). 
The observed RNA nanopores under atomic force microscope size and shape is in 
agreement to our design, confirming the successful self-assembly of RNA nanopores. 
Characterization of RNA nanopore insertion into cellular and lipid bilayer membrane 
To study whether RNA nanopore can interact with cellular membrane, RNA 
nanopore with and without anchored cholesterol and several other controls, were incubated 
with LnCap cell. Cy5 fluorophore was conjugated to these structures to track the interaction. 
The results have shown only cholesterol anchored RNA nanopore group displayed strong 
cy5 signal in cell membrane indicating cholesterol anchored RNA nanopore group inserted 
into the cell membrane (Fig 6.4).  Similar results has also been verified in giant unilamellar 
vesicles that only RNA nanopore with anchored cholesterol can insert into the lipid 
membrane of giant unilamellar vesicles (Data not shown).   
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Figure 6.4 Insertion of RNA nanopores to cellular membrane: The confocal images of 
LnCap cell after incubation with RNA nanopore contain cholesterol. RNA nanopores 
without cholesterol, single strand RNA and cell only used as the negative control as 
indicated in the image. The DAPI and Alexa 488 were used to stain the cell nucleuses and 
actin. Cy5 fluorophore conjugated these structure was used to track the interaction. 
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To incorporate origami designed RNA nanopore into planar lipid membranes, 
direct insertion of cholesterol-anchored RNA nanopore with detergent n-octyl-oligo-
oxyethylene was first tried but no insertion was observed (data not shown). This may be 
because the hydrophobicity of two cholesterol was not strong enough to overcome the 
energy barrier of inserting into lipid bilayer. Therefore, a two-step procedure was 
employed(13) for this design. Briefly, DPhPC lipids in chloroform were dehydrated to 
eliminate solvents first and then rehydrated with buffer containing 250 mM sucrose and 
purified origami designed RNA nanopore with a final concentration 250 nM. The 
multilamellar lipid-RNA nanopore suspension was then extruded through 400 nm 
polycarbonate membrane filters to generate uniform unilamellar liposomes with the RNA 
naopore embedded in the membrane. The resulting liposome-RNA nanopore complex was 
fused with a planar lipid membrane to generate planar membrane-embedded RNA 
nanopore. Electrophysiological properties of membrane-embedded RNA nanopore was 
characterized by single channel conductance assay. As revealed in a continuous current 
trace, the RNA nanopore insertion were observed (Fig. 6.5A). The insertion of single RNA 
nanopore results in various current jump under an applied potential of 50 mV in conducting 
buffer (1 M KCl, 5 mM HEPES, pH 8). As revealed in Fig.6.5B, the conductance 
distribution of is wide. This wide distribution is attributed to simultaneous insertion of 
multiple RNA nanopore or multiple RNA nanopore aggregated together.  
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Figure 6.5 Characterization of origami designed RNA nanopore into lipid bilayer. (a) 
Current trace of single channel insertion under 50 mV applied voltage (b) Conductance 
distribution of origami designed RNA nanopore. Condition: 1M KCl 5mM Hepes, pH 8. 
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Due to the insertion rate of RNA nanopre is relative low with two anchored 
cholesterol, another design with three anchored cholesterol and a bundle of six RNA 
duplexes was constructed. Direct incubation of the three anchored cholesterol RNA 
nanopore with plannar lipid bilayer has resulted distinguish stepwise current jump 
(Fig.6.6B). Two step prepared liposome-RNA nanopore complex has also resulted in 
similar stepwise current jump (Fig.6.6A). The conductance distribution of this RNA 
nanopore is also wide under 0.4M KCl, 5mM Hepes, pH8 (Fig.6.6C,D). The wide 
distribution of this RNA nanopore is also possibly due to multiple nanopores aggregated 
together cholesterol group. This is also revealed in the assemble gel in which the anchored 
cholesterol RNA nanopore stuck in the well.  
Characterization of peptide translocation through RNA nanopore 
One of possible way toward protein sequencing is to digest protein into amino acids 
and discriminate them sequentially using nanopore. However, detection of short amino 
acids by nanopore is still challenging due to the ultra-fast translocation speed. In this study, 
translocation of poly arginine with 2, 4, 6, 8, 10 amino acids through RNA nanopore were 
measured and compared.  
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Figure 6.6 Characterization of six bundled RNA nanopore into lipid bilayer. (a) 
Current trace of multiple RNA nanopore/liposome insertion under -50 mV applied voltage 
(b) Conductance distribution of RNA nanopore/liposome. Condition: 0.4 M KCl 5mM 
Hepes, pH 8. 
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Supp.Fig.6.1 presents typical current trace of R2, R4, R6, R8, and R10 
translocation through RNA nanopore with negative 50 mV applied voltage. All of these 
peptides has displayed similar current blockade. As shown in Supp.Fig.6.1, R2 has 
displayed lower capture rate compared with other peptides, which may be because the 
translocation speed is too fast for R2 and many events has been filtered. The dwell time for 
each peptides was derived as previously described (220). The dwell time of R2, R4, R6, 
R8, and R10 are 0.14±0.01, 0.22±0.01, 0.17±0.01, 0.15±0.01, and 0.28±0.03ms 
(Supp.Fig.6.2). In this study, we have also observed that only positive or neutral charged 
peptide are allowed to pass through RNA nanopore, whereas negative charged DNA or 
peptide are not allowed to pass through RNA nanoproe which may be due to the 
electrostatic repulsing force between RNA nanopore and negative charged DNA or peptide 
(data not shown). To study the folding of protein and even sequencing protein, several 
attempts have been made such as adjusting pH (198) and using the AAA+ unfoldase ClpX 
to slow down peptide translocation(225). So far, short peptide detection still has not been 
reported. In this study, short amino acids as short as only two have been successfully 
detected in our platform, which has potential for applying protein sequencing in the future.  
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Supplementary Figure 6.1 Typical current trace of poly arginine R2, R4, R6, R8, and R10 
translocation through RNA nanopore. Condition:-50 mV, 0.4M KCl 5mM Hepes, pH 8. 
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Supplementary Figure 6.2 Dwell time distributin of poly arginine R2, R4, R6, R8, and 
R10 translocation through RNA nanopore. Condition:-50 mV, 0.4M KCl 5mM Hepes, pH 
8.  
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CONCLUSION 
In this study, we have successfully designed, constructed and assembled two 
different biomimetic RNA-based nanopore. The assembled RNA based nanopore anchored 
with cholesterol have been demonstrated insertion into cellular and lipid membrane. Short 
amino acids as short as two have been first time detected and characterized. De novo 
designed membrane channel can provide numerous advantages compared protein 
membrane channel, such as tunable size and its functionality, ease of construction, scale 
up and modification. Due to RNA unique physical/biochemical properties, biomimetic 
RNA-based Nanopore have the potential to be applied for sensing and protein sequencing.   
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Chapter 7: Future Direction and Perspectives of the Field 
CONCLUSIONS AND FUTURE DIRECTION: 
This thesis work has successfully applied phi29 connector nanopore for antibody 
detection, developed several new biological nanopore and biomimetic nanopore using 
RNA nanotechnology, and applied them for short peptide detections.  Nanopore technology 
has emerged as a cost-effective and high-throughput single molecule detection method, 
holding great potential for sensing and biopolymer sequencing over the last two 
decades(3,4,69).  Chapter 2 demonstrated that EpCAM antibody can be detected and 
discriminated from the background events by phi29 connector nanopore. Chapter 3 
explored more biological nanopore from other bacteriophages and discovered a three step 
gating property that is common to DNA packaging motors of bacterial viruses. Chapter 4 
expanded the applications of portal protein to study the translocation of peptides and the 
dynamics of peptide oligomeric states in real-time at single molecule level. Chapter 5 has 
successfully detected and distinguished different lengths of short peptides under optimize 
condition. Chapter 6 has successfully constructed a new biomimetic nanopore using RNA 
nanotechnology and applied for short peptides detection.  
A wide range of analytes ranging from ions, small molecules, macromolecules, to 
biopolymers have been detected successfully using nanopore. However, most of these 
development were still in the laboratory stage. How to improve the sensitivity, stability and 
specificity especially using clinical sample which is often in the presence of many 
impurities is still the major bottleneck to transform nanopore for clinical use. Also, more 
effort should be made to explore detectable capability such as protein and peptide 
sequencing, protein structure and folding studies.  
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Continuous improvement and engineering of currently available nanopores and 
exploration of new channels and pores are still needed. Although many biological channel 
have been developed and applied for various applications in the last decade, several 
challenges still remains, such as lacking knowledge on structure-function of  available 
protein channel, low sensitivity and specificity, and limited detectable analytes. In order to 
obtain high sensitivity and specificity, different analytes requires unique protein nanopore 
with different shape, size, physical dimensions and hydrophilic/hydrophobic properties.  
Compared with traditional DNA sequencing methods, nanopore-based sequencing 
offers considerable advantages such as ultra-low cost and fast, long readout, label-free, low 
sample volume and no applications required. Several key challenges that used be the 
bottlenecks in nanopore-based sequencing has been resolved. First, the ultra-fast 
translocation of DNA through nanopore which is far beyond the electronic detection limits, 
have been resolved by introducing enzymes or motors such as DNA polymerase or 
exonucleases. The second challenge is spatial resolution which is able to detect single bases 
ideally, however, most of the times in many protein nanopore at least several nucleotides 
reside within the constrict site at any given point making it difficult to detect a single 
nucleotide. Noblegen Company employed a strategy that can convert each nucleotide into 
multiple same nucleotide in the DNA sequence through a process called “cicular DNA 
conversion” therefore expanding the special resolution (86). Another strategy employed by 
Oxford Nanopore in R9 pore is that analyzing more than 5 bases at any one time and the 
sequence is then decoded by a reference map (84,104,237). The third challenge is the low 
resolution of distinguishing the four bases due to the much closed structure. To solve this 
problem, Genia Company developed a technology that can modify the four nucleotides 
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with different sized polymer tag and then be differentiated after cleavage by the nanopore. 
Another common strategy is the engineering the nanopores to enhance the recognition 
capability. It is reported that over 700 mutants of R9 have been screened in Oxford 
Nanopore (82). The challenge for the “exonuclease approach”, which is initially developed 
in a-HL but no further data revealed by Oxford Nanopore, is the subsequently released 
nucleotide is not guaranteed to move in to the pore directly or in a strictly sequential 
manner. One possible approach to resolve this challenge is to fix the exonuclease to the 
nanopore in specific site and direction ensuring each released nucleotide can move into the 
pore. Other challenges including the instability of membrane, integrated circuits that enable 
massively parallel single-molecule DNA sequencing, and software to analyze the data have 
also been resolved by Oxford Nanopore. The remaining challenge is the accuracy which is 
still low compared with current sequencing technologies. To enhance accuracy, it still need 
many works such as protein engineering, large scale screening, exploration new nanopore 
and improvement of the algorithmic in the future.  
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